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ABSTRACT OF THE DISSERTATION

Hypochlorous Acid Mediated Damage of Chromatin
By
Joseph Insung Kang
Doctor of Philosophy, Graduate Program in Biochemistry
Loma Linda University, May 2008
Dr. Lawrence C. Sowers, Chairperson

Hypochlorous acid (HOC1), the primary product of activated neutrophils at sites
of inflammation, can damage both DNA and associated histone proteins. HOC1 damage
to cytosine bases in DNA generates the chlorination damage products 5-chlorocytosine
(C1C) and 5-chlorouracil (C1U) as well as the oxidation damage products 5hydroxycytosine (HOC) and 5-hydroxyuracil (HOU). Histone damage by HOC1 can be
measured by quantitation of 3-chlorotyrosine and 3,5-dichlorotyrosine, stable and unique
markers of protein damage caused by HOC1. The studies presented here investigate how
and where these damage products occur and what implications they might have in the
correlation between chronic inflammation and carcinogenesis. The first study develops a
strategy to place C1C into synthetic oligonucleotides providing a tool to study the
biochemical and biophysical properties in DNA. This allowed further studies that show
C1C could perturb epigenetic patterns in DNA by causing inappropriate
methyltransferase-mediated cytosine methylation and by increasing the binding affinity
of methyl-binding proteins involved in subsequent histone modification and chromosome
condensation. In order for C1C to have the epigenetic effects proposed, it would have to
be formed specifically in a CpG dinucleotide in duplex DNA. Utilizing mass tagging to
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show sequence specific chlorination by HOC1, the data provides direct evidence for the
formation of C1C in a CpG dinucleotide. Emerging data shows the importance of histone
modifications on gene transcription, replication, and repair. The histone proteins are in
close proximity to DNA and have higher reactivity of protein side chains than DNA. 3Chlorotyrosine and 3,5-dichlorotyrosine were measured as stable markers of histone
damage by HOC1. The formation of 3-chlorotyrosine and 3,5-dichlorotyrosine in the core
histone proteins, H2A, H2b, H3, and H4, upon reaction with HOC1 was observed and
quantified. The preferential chlorination of tyrosine residues within 4 residues of a lysine
or histidine was also observed. The results of this series of studies provide a better
understanding of HOC1 damage products of DNA and histone proteins at sites of
inflammation and shed light on the mechanisms by which inflammation contributes to
carcinogenesis.

xiv

CHAPTER ONE
INTRODUCTION

Hypochlorous Acid
Hypochlorous Acid and Inflammation
Inflammation is a normal physiological response to a foreign agent. Macrophages,
upon recognition of a foreign microorganism, will release chemical signals or mediators
of inflammation which attract neutrophils. Neutrophils are the primary leukocyte at sites
of inflammation during the first 24 to 72 hours. The phagocytic leukocytes, including
neutrophils, eosinophils, and macrophages, generate reactive oxygen species (ROS),
including hypochlorous acid (HOC1), to kill invading microorganisms (Babior, 2000;
Nauseef, 2007).
Hypochlorous acid (HOC1), the active ingredient of household bleach, is the
primary reactive oxygen species (ROS) produced by activated neutrophils at sites of
inflammation (Babior, 2000; Dukan et al, 1999; Fang, 2004). NADPH oxidase,
superoxide dismutase, and myeloperoxidase released from phagocytic leukocytes like
neutrophils and macrophages accelerate the production of HOC1 from oxygen (Babior,
2000). Myeloperoxidase (MPO) catalyzes the oxidation of the chloride ion (Cf) by H2O2
to form HOC1.

H2O2 + Cl"

^

HOC1 + OH"
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The efficiency of MPO to form HOC1 at physiological conditions and the powerful anti
microbial action of HOC1 are well accepted (Klebanoff, 2005). Studies estimate that up
to 80% of the hydrogen peroxide generated by activated neutrophils is utilized to form
concentrations of HOC1 in the micromolar to low millimolar range (Weiss et al, 1982;
King et al, 1997; Test and Weiss, 1986; Hussien et al, 2002).
In addition, the quantities of HOC1 produced at sites of inflammation can
overwhelm host defenses and damage host tissue (Weiss, 1989). Following activation,
neutrophils exhibit an abrupt increase in oxygen consumption, called the “respiratory
burst” that leads to the production of the strongly oxidizing HOC1 via MPO. Estimates of
the HOC1 generating capability of 1 x 106 neutrophils (the number of neutrophils found in
0.25 ml of blood) over a 1 to 2 hour time period range from 60 to 560 nanomoles of
HOC1 (Foote et al, 1983; Test and Weiss, 1986; Babior, 2000; King et al 1997). HOC1
can damage host cells by reacting with a variety of biological molecules, including
protein, DNA, RNA, carbohydrates, and lipids (Priitz, 1998; Priitz, 1996; Hawkins et al,
2002; Kulcharyk and Heinecke, 2001; Schraufstatter et al, 1990). The ability of MPO to
catalyze the two electron oxidation of Cf to Cl+ is unique among the animal peroxidase
protein family (Colas and Ortiz de Montellano, 2003). As a result, the detection of
chlorinated products, including nucleosides and proteins, from sites of inflammation in
biological specimens provides a biochemical fingerprint of MPO action (Gaut et al, 2001;
Priitz, 1996; Badouard et al, 2005; Jiang et al, 2003; Hazen and Heinecke, 1997; Hazen et
al, 1999).

2

H0C1 damages DNA
Hypochlorous acid is highly reactive and can induce both oxidation and
chlorination reactions. HOC1 is known to react with DNA resulting in an array of
damage. The major reactions of DNA with HOC1 include oxidation of pyrimidines and
chlorination of cytosine (Whiteman 1997). Thymine yields primarily cis and trans
glycols whereas cytosine generates both chlorination and oxidation damage products
(Whiteman 1999). Hypochlorous acid oxidizes DNA bases to form 5-hydroxyluracil
(HOU), 5-hydroxycytosine (HOC), and thymine glycol. While these oxidized bases are
also observed when DNA is exposed to other reactive oxygen species, 8-chloroguanosine
(C1G), 8-chloroadenosine (CIA), 5-chlorocytosine (C1C), and 5-chlorouracil (C1U) are
chlorinated bases that are unique products of HOC1 or reactive chloramines generated by
HOC1.
When human cells in culture are exposed to 300 pM HOC1 for 10 minutes,
Badouard et al. observed 5-chlorocytosine, 8-chloroadenine, and 8-chloroguanine in
extracted DNA (Badouard et al, 2005). Using a monoclonal antibody specific for HOC1
damaged DNA, Kawai et al. demonstrated the presence of HOC1 damaged DNA at sites
of inflammation in the lung and liver of mice (Kawai et al, 2004). Additionally, studies of
intracellular glutathione levels in erythrocytes exposed to extracellular HOC1 indicate that
the cell membrane is readily crossed by HOC1 (Vissers and Winterboum, 1995; Zavodnik
et al, 2002). These findings suggest that extracellular hypochlorous acid is capable of
damaging the DNA of cells at sites of inflammation.

3

H0C1 damages Proteins
In addition to DNA, HOC1 is known to react with proteins generating numerous
damage products. The ability of HOC1 to oxidize and chlorinate protein functional groups
has been extensively studied using model compounds (Hawkins et al, 2003; Pattison and
Davies, 2001). HOC1 oxidizes the sulfur containing amino acids methionine and
cysteine. HOC1 reacts rapidly with free amines found on lysine and histidine side chains,
free amino acids, and N-terminus of proteins to yield N-chloramines that can be longlived and can further react. The chloramines at the N-terminus and lysine residues can
decompose to form an aldehyde that can participate in cross-linking reactions with DNA
or between proteins (Hawkins et al, 2002; Zaliczynski et al, 1971; Hazen et al, 1998).
HOC1 is also known to form 3-chlorotyrosine, a relatively stable product unique to the
action of HOC1 on proteins (Hazen and Heinecke, 1997), and has been measured in a
variety of human diseases including atherosclerosis, rheumatoid arthritis, asthma, and
Alzheimer’s disease (Zheng et al, 2004; Wu and Pizzo, 2001; Mita et al, 2004; Green et
al, 2004). Finally, HOC1 slowly reacts with the protein backbone and can lead to
fragmentation.
The detection of chlorinated proteins in a biological setting provides a
biochemical fingerprint of MPO action (Gaut et al, 2001; Priitz, 1996; Hazen and
Heinecke, 1997; Hazen et al, 1999). Two potential markers that are relatively stable and
unique damage products of HOC1 are 3-chlorotyrosine and 3,5-dichlorotyrosine
(Chapman et al, 2000; Chapman et al, 2002). Recently, Whiteman and Spencer found that
3-chlorotyrosine can be degraded when exposed to peroxynitrite and activated
inflammatory cells suggesting that measurement of 3-chlorotyrosine alone could lead to
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an underestimation of the true extent of protein chlorination (Whiteman and Spencer,
2008). Chlorinated bacterial tyrosines have been measured from stable isotope enriched
tyrosine labeled bacteria fed to polymorphonuclear neutrophils (PMNs) (Chapman et al,
2002; Rosen et al, 2002; Painter et al, 2006). As expected, HOC1 mediated damage is not
confined to bacterial targets. The majority of chlorinated proteins measured originated
from the host, probably due to the excess of host versus microbial targets in the local
environment (Chapman et al, 2002).
Contemporary understanding of the mechanism of tyrosine chlorination in
proteins is based upon the observations of 3-chlorotyrosine formation in short peptides,
apolipoprotein A-l, and other small proteins (Bergt et al, 2004; Domigan et al, 1995;
Pattison et al, 2007). Direct chlorination of tyrosine to 3-chlorotyrosine is slow (40 M'V
i

) (Hawkins et al 2002); however, a tyrosine residue within the YXXK sequence motif

can be rapidly chlorinated (Pattison and Davies, 2001; Bergt et al 2004). Bergt et al. used
mass spectrometry to determine that Tyr-192 of apolipoprotein A-l is efficiently
chlorinated and argued that Lys-195 in the sequence YHAK facilitated chlorination of
Tyr-192 (Bergt et al 2004). Based on the chlorination of tyrosine in synthetic peptides,
they concluded that the sequence motif YXXK or KXXY favors tyrosine chlorination,
particularly in a-helicies (Bergt et al 2004). Pattison and Davies, however, note that
histidine can form a chloramine that in turn can accelerate tyrosine chlorination and they
point out the presence of His-193 in the sequence of high density lipoprotein (Pattison
and Davies, 2005). More recently, Pattison et al. showed that tyrosine consumption was
enhanced in both insulin and lysozyme when compared to the corresponding N-acetyl
amino acid mixtures (Pattison et al, 2007). These results show that chloramine
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formation, and subsequent intramolecular chlorine transfer is a major mechanism of
chlorination of tyrosine residues in proteins by HOC1, and that tyrosine chlorination by
HOC1 can be accelerated by nearby amines.
Hypochlorous acid is expected to rapidly react with histone amines, thiols,
thioethers, and disulfides. The second order rate constants for the oxidation or
chlorination of methionine, cysteine, histidine, and lysine side chains have been reported
with values between 104 and 107 M'V1 (Pattison and Davies, 2001). By contrast, the
reaction of HOC1 with double stranded DNA is slow (101 M'V1); although the exposed
amines of single stranded DNA react faster (102 - 104 M'V1) (Hawkins et al, 2002;
Hawkins and Davies 2002). The oxidation of methionine or cysteine residues in proteins
is likely reversible due to the actions of the protein repair enzymes, methionine reductase
and glutathione reductase (Weissbach et al, 2005; Moskovitz, 2005; Ghezzi, 2005). The
reaction between HOC1 and lysine or histidine residues results in the formation of an
unstable chloramine that can react further with DNA or other amino acids such as
tyrosine (Hawkins et al, 2002; Bergt et al, 2004; Pattison and Davies 2005). The kinetics
of protein damage indicate that histone proteins might be targets of extracellular HOC1.
As stated in the previous section, data suggests that extracellular HOC1 can
damage DNA of cells at sites of inflammation. In parallel experiments with Kawai et al..
Kato et al. immunohistochemically demonstrated the presence of dihalogenated tyrosine
at sites of inflammation in the liver of mice after intraperitoneal injection with
lipopolysaccharide using a monoclonal antibody specific for dihalogenated tyrosine
(Kato et al, 2005). Evidence of HOC1 mediated DNA damage with simultaneous
demonstration of HOC1 mediated protein damage combined with close proximity of
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readily reactive histone protein side chains to DNA suggest that extracellular
hypochlorous acid is capable of damaging the chromatin of cells at sites of inflammation.

Epigenetics and Cancer
The concept of epigenetics may offer a partial explanation to the diversity of
phenotypes observed within a population that cannot be explained solely by classic
genetics. The modem definition of epigenetics is heritable changes in gene expression
that are not due to any alteration in the DNA sequence (Holliday, 1987). Epigenetic
mechanisms are responsible for the organization and compaction of the genome in order
to make accessible for transcription genes needed for particular cell types and to silence
unneeded genes and potentially harmful sequences. Epigenetic alterations include
changes in the methylation status of cytosine bases in the context of CpG dinucleotides
and covalent modifications of amino acid residues in the histones around which the DNA
is wrapped. Epigenetic mechanisms influence multiple cellular processes including cellcycle control, DNA repair, angiogenesis, and cell migration, and alterations of these
mechanisms have been noted in multiple human cancers (Esteller, 2005; Esteller, 2008;
Fog et al, 2007; Gronbaek et al, 2007).

DNA Methylation
In humans, DNA methylation occurs in cytosines that precede guanines, CpG
dinucleotides, in CpG-rich regions known as CpG islands that span the 5’ end of the
regulatory region of many genes (Herman and Baylin, 2003; Weber et al, 2007). 5methylcytosine (5mC) is generated when a methyl group from S-adenosylmethionine
(SAM) is added to the 5 position of the cytosine pyrimidine ring by DNA
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methyltransferases (DNMTs) (Ehrlich and Wang, 1981; Riggs and Jones, 1983). During
DNA replication, DNA maintenance methyltransferase, DNMT1, is mainly responsible
for the methylation of cytosines within hemimethylated CpG sequences resulting from
semi-conservative DNA replication; thus preserving the methylation pattern on the
parental strand (Ehrlich and Wang, 1981; Riggs and Jones, 1983; Bestor, 2000).
Methylation of previously unmethylated DNA, de novo methylation, may occur in early
embryonic stem cells and cancer cells mediated by DNMT3a and DNMT3b (Okano,
1999). Although the processes that initiate de novo methylation have yet to be
elucidated, it is well recognized that epigenetic gene regulation entails the methylation of
selective cytosine within CpG dinucleotides in promoter regions of genes to facilitate
transcriptional inactivity.
Although genomic damage has been measured in many human tumors,
emerging data demonstrate that epigenetic changes contribute substantially to cancer
development (Feinberg and Tycko, 2004; Jones and Baylin, 2002; Esteller, 2008). An
important component of the molecular basis of epigenetic control involves the enzymatic
methylation of cytosine residues in CpG dinucleotides in promoter regions of specific
genes. Specific methyl-binding proteins selectively bind to these methylated DNA
sequences and recruit additional proteins that covalently modify local chromatin
structure, thereby affecting gene expression (Bird and Wolffe, 1999). Many tumor
suppressor genes and transforming oncogenes are under epigenetic control, and therefore
perturbations in epigenetic signals can result in the loss of tumor suppressor expression or
inappropriate oncogene expression (Esteller, 2008; Merlo et al, 1995; Esteller et al, 2001;
Weber et al, 2007; Ballestar et al, 2003). Epigenetic changes include global DNA
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hypomethylation, increased frequency of hypermethylated CpG islands, and an increased
histone-modification imbalance (Esteller, 2008). These alterations are abundant in
human cancer, but the mechanisms that change these epigenetic signals are unknown.
Specifically, aberrant hypermethylation of CpG islands in the promotor region of
tumor suppressor genes occurs during carcinogenesis and are commonly found in human
tumors (Esteller, 2008; Baylin, 2005; Das, 2004). Loss of tumor suppressor expression is
likely to contribute to both initiation and progression of carcinogenesis although the exact
mechanisms are unknown. Inactivation of tumor-suppressor genes via hypermethylation
of the CpG island promoter can affect genes involved in the cell cycle, DNA repair,
metabolism of carcinogens, apoptosis, cell to cell interaction, and angiogenesis that are
all involved in cancer development (Esteller, 2007; Herman and Baylin, 2003). Recent
studies have revealed maps of hypermethylation of CpG islands that suggest 100 to 400
hypermethylated CpG islands in promoter regions of a given tumor (Esteller 2007).

Histone Modifications
DNA methylation is not an independent phenomenon, but occurs in a complex
chromatin network and is influenced by the modifications in histone structure that are
commonly disrupted in cancer (Bernstein et al, 2007; Kouzarides, 2007; Seligson et al,
2005). Histone proteins are intimately involved in gene regulation and are much more
than DNA-packaging proteins. Post-translational histone modifications, including
acetylation and methylation, can alter gene expression independent of DNA methylation
(Bachman et al, 2003; Strunnikova et al, 2005; Zhao et al, 2005; Fog et al, 2007).
The core histones, H2A, H2B, H3, and H4, store epigenetic information through
numerous post-translational modifications, including acetylation, methylation,
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phosphorylation, and ubiquitination that occur primarily at specific amino acid residues
in the histone tails (Kouzarides, 2007; Berger, 2002; Khan and Krishnamurthy, 2005).
These modifications affect gene transcription and DNA repair and form the basis of the
“histone code” that is believed to regulate access to associated DNA by DNA binding
and/or modifying proteins (Jenuwein and Allis, 2001; Strahl and Allis, 2000). Histone
modifications not only occur on different histone residues like lysine and arginine, but
they occur on different histone proteins and histone variants like histone H3.3.
Additionally, there are numerous chemical modifications like acetylation and methylation
that are complicated further by degrees of modifications like mono-, di-, and
trimethylation of lysines. These layers of complexity along with possible unknown
modifications obscure the landscape of histone modifications that affect a variety of
nuclear processes including gene transcription, DNA replication, DNA repair, and
chromatin remodeling.
Generally, histone acetylation is associated with gene activation (Bernstein et al,
2007). Deacetylation of histones H3 and H4, loss of H3K4 trimethylation, and gain of
H3K9 methylation and H3K27 trimethylation are associated with hypermethylation of
CpG islands and gene inactivation (Ballestar et al, 2003; Jones and Baylin, 2007). While
the biological significance of most post-translational modifications has yet to be
elucidated, the critical role that known modifications play in DNA replication,
transcription, and DNA repair suggest that damage to histone proteins may adversely
affect their biological function. The importance of histone modifications in
carcinogenesis is illustrated by the loss of function for histone modifying proteins in
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human cancers (Oshimo et al, 2004). Recent evidence has even identified global changes
in histone modifications in cancer cells (Seligson et al, 2005; Fraga et al, 2005).

HOC1 Medicated Damage and Epigenetic Signals

HOC1 Mediated DNA Damage
HOC1 derived from activated neutrophils is known to react with DNA resulting in
an array of damage. Among the potential damage products of cytosine are 5hydroxycytosine (HOC) and 5-chlorocytosine (C1C) as well as the corresponding
deamination products 5-hydroxyuracil (HOU) and 5-chlorouracil (C1U). Among these,
the formation of HOC, HOU and C1U could lead to miscoding, base misincorporation,
and mutation if unrepaired prior to DNA replication (Purmal et al, 1994; Suen et al, 1999;
La Francois et al, 2000; Thiviyanathan et al, 2005; Simon et al, 2006; Thiviyanathan et
al, 2007). Also, C1U accumulation in DNA has been shown to induce sister chromatid
exchanges and mutations (O’Neill et al, 1983; Morris, 1993). Repair activities have been
identified for each of these bases (Wood et al, 2001; Wagner et al, 1996; Liu et al, 2002;
Fujimoto et al, 1997; Bennett et al, 2006), which might reduce their mutagenic potential.
However, HOC is considered to be one of the most mutagenic of all damage products.
Transition mutations at cytosine positions, and at the CpG dinucleotide in particular,
account for many of the single base changes observed in human tumors (Jones et al 1992;
Schmutte and Jones, 1998; Pfeifer, 2006). While spontaneous deamination of 5methylcytosine is often the explanation for transition mutations at CpG dinucleotides,
HOCl-mediated damage may also contribute to these observed mutations.
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In contrast, C1C would not be expected to be miscoding; however, C1C may be a
persistent lesion in DNA, as it is not a substrate for any of the uracil glycosylases yet
examined, and it is unlikely to be a substrate for most of the other known glycosylases.
Experiments with CIC-containing oligonucleotides in HeLa cell nuclear extract failed to
reveal substantial repair activity targeted against C1C (Kang et al, 2004). Additionally,
C1C appears to be resistant to further oxidation by oxidants such as peroxynitrite in vitro
and may be more stable than other oxidized or chlorinated DNA base products such as 8hydroxyguanine, 5-hydroxycytosine, 8-chloroadenine, and 2-hydroxyadenine (Whiteman
et al, 2002).
The coding potential of C1C is predicted to be similar to that of C, and therefore,
C1C is unlikely to be a miscoding lesion, however, the formation of C1C in the CpG
dinucleotide could perturb epigenetic patterns in DNA. As previously stated.
hypermethylation of tumor suppressor genes is common in human cancers (Esteller,
2008; Baylin, 2005; Das, 2004). Chlorination of cytosine residues in the CpG
dinucleotide could recruit methyl binding proteins and/or methylases, setting in motion
the cascade of events that render specific genes transcriptionally inactive. During tumor
progression, unmethylated CpG islands acquire one or more methylated CpG's, and
within a few generations, evolve to dense regional hypermethylation and gene silencing
describing a process referred to as “methylation seeding” (Esteller, 2001). The
mechanism of methylation seeding is unknown, but the involvement of inflammationmediated DNA damage, specifically cytosine chlorination, could be important.
Using synthetic oligonucleotides with C1C at specific sequence contexts
Valinluck et al. showed that C1C in a CpG sequence context mimics 5-methylcytosine
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(5mC) by enhancing the binding of methyl-CpG-binding domain (MBD) of methyl-CpGbinding protein 2 (MeCP2) (Valinluck et al, 2005). Additional studies show that C1C can
cause inappropriate cytosine methylation by human DNA maintenance methyltransferase,
DNMT1 (Valinluck and Sowers, 2007). Therefore, although C1C would not be expected
to be miscoding, the formation of C1C in the CpG dinucleotide could perturb epigenetic
patterns in DNA by causing inappropriate methyltransferase-mediated cytosine
methylation and by increasing the binding affinity of methyl-binding proteins involved in
subsequent histone modification and chromosome condensation (Valinluck et al, 2005;
Valinluck and Sowers, 2007).

HOC1 Mediated Histone Damage
HOC1 mediated damage of histone proteins has yet to be examined. The core
histone proteins are rich in the basic amino acids histidine, arginine, and lysine that can
form reactive chloramines when reacted with HOC1. As previously stated, tyrosine
residues within the YXXK sequence motif can be rapidly chlorinated (Pattison and
Davies, 2001; Bergt et al 2004). Histones H2A, H2B, and H4 all have the YXXK/KXXY
sequence motif identified as a preferred site of tyrosine chlorination (Bergt et al, 2004).
The HOCl-specific protein damage products 3-chlorotyrosine and 3,5-dichlorotyrosine
have been used as markers of inflammation mediated protein damage (Zheng et al, 2004;
Wu and Pizzo, 2001; Mita et al, 2004; Green et al, 2004; Chapman, 2002). While 3chlorotyrosine and 3,5-dichlorotyrosine formation might directly affect histone function,
3-chlorotyrosine and 3,5-dichlorotyrosine can be measured as markers of all types of
HOC1 induced damage of histone proteins.
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Evidence of cellular DNA damage by H0C1 and the close proximity of more
readily reactive histone protein side chains suggest that the core histone proteins can also
be damaged by HOC1. HOC1 mediated oxidation and chlorination of histone proteins at
sites of inflammation, if not repaired, might modify gene expression and lead to cancer
formation. For example, HOC1 damage to a histone residue critical for regulating gene
expression might lead to altered gene expression leaving the cell susceptible to further
genomic changes. An additional implication is that the chemically reactive chloramine
intermediate on a histone protein can react with associated DNA. For example, lysine
chloramines can hydrolyze to form an aldehyde or a radical which can then react with
DNA causing single-strand breaks and DNA-protein crosslinks (Hawkins et al, 2002).
Furthermore, reactive chloramines may accelerate chlorination damage of DNA in
nucleosomes when compared to naked DNA exposed to HOC1.

Inflammation and Cancer
In 1863, Virchow hypothesized a link between cancer and inflammation when he
observed the presence of leukocytes in neoplastic tissue. Epidemiological evidence links
inflammatory bowel disease with colorectal cancer, chronic hepatitis B or C infections
with hepatocellular carcinoma, and chronic gastric inflammation from Helicobacter
pylori infection with gastric cancers (Thun et al, 2004; Hussain et al, 2003). Persistent or
frequent inflammation appears to be a risk factor for cancer. The primary, non-hereditary
risk factor for colorectal cancer is the presence of inflammatory bowel disease (Itzkowitz
and Yio, 2004). Other examples of oxyradical overload diseases that confer high cancer
risk include hemochromatosis for hepatocellular carcinoma, human paillomavirus
infection for cervical cancer, prostatitis for prostate cancer, Schistosoma hematobium
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infection for bladder cancer, and gastroesophageal reflux disease for esophageal cancer
(Hussain et al, 2003).
About 1 out of 4 cancer cases worldwide can be attributed to chronic infection
and inflammation (Hussain and Harris, 2007). Immune cells can regulate almost every
stage of cancer development (de Visser, 2006). Inflammation requires coordination of
the innate and adaptive immune systems, and any breakdown in the strict control of these
components can lead to chronic inflammation. Chronic inflammation may produce an
environment that can favor the initiation and progression of malignant disease due to the
constant supply of reactive nitrogen and oxygen species, cytokines, and growth factors
(Balkwill et al, 2005; Bartsch and Nair, 2006; Coussens and Werb, 2002). Mediators of
inflammation like growth factors, cytokines, and free radicals can lead to both genetic
and epigenetic alterations including point mutations in tumor suppressor genes, DNA
methylation changes, and post-translational modifications of critical proteins like DNA
repair enzymes and caspases. These modifications affect fundamental pathways
responsible for normal cellular homeostasis leading to initiation and promotion of cancer
(Hussain and Harris, 2007).
Furthermore, studies link chronic inflammation to epigenetic changes. Evidence
supports an association between chronic inflammation and DNA hypermethylation both
in the presence and absence of microbial infection (Shames et al, 2007). H. pyloriinfected patients with and without cancer show a 5-300 fold higher methylation pattern in
all 7 of the CpG islands examined compared to H. pylori negative patients (Maekita et al,
2006). Additionally, in H. pylori negative individuals, DNA methylation levels
correlated with gastric cancer risk (Nakajima et al, 2006). Moreover, patients with
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cancer-prone chronic inflammatory diseases like ulcerative colitis and Barrett’s
esophagus show hypermethylation in pi6, RUNX3, HPP1, and MLH1 (Issa et al, 2001;
Schulmann et al, 2005). These studies support the assertion that inflammation mediated
damage to cytosine by HOC1 can alter methylation patterns and lead to epigenetic
perturbations (Valinluck et al, 2005; Valinluck and Sowers, 2007).

Approach of Studies
In order to study the biochemical and biophysical properties of the HOC1
mediated DNA damage product, 5-chlorocytosine, a method to place 5-chlorocytosine in
synthetic oligonucleotides was developed, and the subsequent oligonucleotides were
characterized using a barrage of biochemical techniques including mass spectrometry and
enzyme assays. In order for C1C to have the biological significance proposed by
Valinluck and Sowers, C1C would have to be formed within a CpG dinucleotide sequence
context (Valinluck and Sowers, 2007). The use of mass tagging to show sequence
specific chlorination while retaining the sensitivity of standard mass spectrometry
techniques provides direct evidence for the formation of C1C in a CpG dinucleotide.
Emerging data on the importance of histone modifications on gene transcription,
replication, and repair along with the close proximity to DNA and higher reactivity of
protein side chains of histone proteins led us to measure 3-chlorotyrosine and 3,5dichlorotyrosine as stable markers of histone damage by HOC1 by sensitive negative
chemical ionization mass spectrometry techniques. The HOC1 mediated damaged
histones were further analyzed by various mass spectrometry techniques to identify
specific tyrosine residues prone to chlorination in specific sequence contexts.
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Significance of Studies
The correlation between inflammation and an increased risk of cancer is widely
accepted. However, the mechanism by which inflammation contributes to carcinogenesis
is unknown. HOC1 generated at sites of inflammation may damage DNA and histone
proteins and alter the expression of genes by affecting epigenetic mechanisms. The
development of a method to incorporate C1C into synthetic oligonucleotides paved the
way for biochemical studies that showed the formation of C1C in the CpG dinucleotide
could perturb epigenetic patterns in DNA by causing inappropriate methyltransferasemediated cytosine methylation and by increasing the binding affinity of methyl-binding
proteins involved in subsequent histone modification and chromosome condensation
(Valinluck and Sowers, 2007). Central to understanding the impact of HOCl-mediated
damage on epigenetic patterns is information on the reactivity of cytosine in a CpG
dinucleotide in duplex DNA. The use of mass tagging showed direct evidence for the
formation of C1C in a CpG dinucleotide in duplex DNA upon reaction with HOC1.
Our interest in the core histone proteins in large part derives from their biological
importance in regulating access to DNA during replication, transcription, and DNA
repair. To our knowledge, this is the first series of studies looking at the HOC1 mediated
damage of histone proteins. These studies demonstrate that histone proteins can be
damaged by HOC1 and the damage can be quantified by measuring the HOC1 mediated
protein damage biomarkers, 3-chlorotyrosine and 3,5-dichlorotyrosine. The results from
these experiments provide the basis for efforts to detect HOC1 damage of histone proteins
in human cells at sites of inflammation. The results of the series of studies in this
dissertation provide a better understanding of HOC1 damage products of DNA and
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histone proteins at sites of inflammation, and shed light on the mechanisms by which
inflammation contributes to carcinogenesis.
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A. Abstract
Recent studies have shown that reactive chlorine species, derived from
myeloperoxidase-mediated inflammation responses, can modify DNA bases generating
5-chloropyrimidines. The chlorinated adducts could be mutagenic or perturb DNAprotein interactions, however, the biological significance of these adducts is as yet
unknown. We report here a method for the synthesis of 5-chlorocytosine (C1C)containing oligonucleotides that will be used in subsequent biochemical and biophysical
studies to determine the consequences of pyrimidine chlorination. The C1Cphosphoramidite synthon is obtained by chlorination of 2’-deoxyuridine followed by
conversion to the 04-ethyl analogue. The amino group needed to form the corresponding
cytosine derivative is added by displacement of the 04-ethyl group during ammonia
deprotection. A battery of methods, including mass spectrometry, has been used to
characterize oligonucleotides containing C1C. Following oligonucleotide synthesis and
deprotection, only trace amounts of the deamination product 5-chlorouracil can be
detected by enzymatic cleavage of duplex oligonucleotides with the mispaired uracil
glycosylase, MUG. In contrast to previous reports, we find that C1C is more stable in
DNA than anticipated. Approximately 20% C1C is lost under standard formic acid
hydrolysis conditions (88% formic acid, 140 C, 30 min), while only 5% is recovered as
5-chlorouracil (C1U).
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B. Abbreviations
MPO, myeloperoxidase; HOC1, hypochlorous acid; H2O2, hydrogen peroxide;
ONOO', peroxynitrite; MUG; E. coli mismatch uracil DNA glycosylase; UDG, uracil
DNA glycosylase; CldC, 5-chloro-2,-deoxycytidine; CldU, 5-chloro-2,-deoxyuridine;
C1C, 5-chlorocytosine; C1U, 5-chlorouracil; CID, collisionally induced dissociation,
TMS, Trimethylsilyl group

C. Introduction
It is now well established that the DNA in living cells is constantly damaged by
endogenous chemical reactions (1,2). Recent reports suggest that the array of potentially
damaged DNA bases must now be expanded to include those derived from both
chlorination and bromination. 5-chlorocytosine (C1C), 5-chlorouracil (C1U), and 5bromouracil (BrC) have been identified as products of myeloperoxidase-mediated DNA
damage (3-7). The halogenated pyrimidines could potentially help to explain the link
between host inflammation responses and the development of some cancers.
At sites if inflammation, activated neutrophils generate hydrogen peroxide (H2O2)
and release the heme enzyme, myeloperoxidase (MPO, ref 8). MPO catalyzes the
oxidation of the chloride ion (Cf) by H2O2 to form hypochlorous acid (HOC1):

H2O2 + Cf

^

HOC1 + OH’

It is estimated that up to 80% of the H2O2 generated by activated neutrophils is utilized to
form HOC1 (9-11). HOC1 is highly reactive and can induce both oxidation and
chlorination reactions. HOC1 can damage host cells by reacting with a variety of
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biological molecules, including protein, DNA, RNA, carbohydrates, and lipids (12-17).
Reactions with proteins can form protein chloramines that can form radicals, proteinDNA cross-links, and DNA fragments (13,17). The major reactions of DNA with HOC1
include oxidation of pyrimidines and chlorination of cytosine (16).
The formation of C1C in DNA by chlorination has been demonstrated directly by
others using both GC/MS and HPLC methods. However, recent studies examining C1C
formation in DNA generally report the measurement of C1U, derived from C1C
deamination during DNA hydrolysis (3-6). As the biological consequences of C1C and
C1U in DNA would be profoundly different, it is important to understand the degree to
which C1C and C1U form in DNA upon exposure to HOC1. The initial reaction between
cytosine and chlorinating species would form a dihydro intermediate prone to
deamination. Dehydration of the corresponding cytosine and uracil intermediates would
yield C1C and C1U, respectively (Figure 1). By measuring C1U as a marker for the
formation of C1C, it is impossible to determine the relative amounts of C1C and C1U
initially formed. Accurate validation of methods to detect the formation of the 5chloropyrimidines therefore requires DNA containing known amounts of each of the
chlorinated pyrimidines.
To further investigate the biological consequences of 5-chloropyrimidines in
DNA, we have developed a synthetic method for the placement of C1C residues at
selected locations by standard phosphoramidite methods. Due to the tendency of 5halocytosine derivatives to deaminate under standard synthetic conditions, we utilized a
method that allows introduction of the amino group during oligonucleotide deprotection
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Figure 1. Scheme for addition of HOC1 to deoxycytosine in DNA. The initial reaction
between cytosine and chlorinating species would form a dihydro intermediate prone to
deamination. Dehydration of the corresponding cytosine and uracil intermediates would
yield C1C and C1U, respectively.
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Acid Hydrolysis?

CldU
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as we described recently for the synthesis of oligonucleotides containing 5-fluorocytosine
(18). The C1C phosphoramidite synthon reported here is obtained by chlorination of 2'deoxyuridine followed by conversion to the 04-ethyl analogue. The amino group needed
to form the corresponding cytosine derivative is added by displacement of the 04-ethyl
group during ammonia deprotection.
We report here an examination of the deamination of C1C during standard
hydrolysis conditions. In contrast to some previous reports, we find that C1C is relatively
stable in DNA. Under standard formic acid hydrolysis conditions (88% formic acid,
140°C, 30 min) approximately 20% of the C1C is lost, but only 5% is recovered as 5chlorouracil (C1U). The methods reported here will assist studies aimed at determining
the biological consequences of C1C in DNA.
D. Materials and Methods
The phosphoramidites of the normal DNA bases and Poly-Pak II cartridges were
obtained from Glen Research. Bacterial alkaline phosphatase and bacterial T4
polynucleotide kinase were obtained from New England Biolabs. Nuclease PI was
obtained from Sigma Chemical Co. N,0-Bis(trimethylsilyl)trifluoroacetamide with 1%
trimethylchlorosilane (BSTFA w/1% TMCS) was purchased from Pierce. Escherichia
coli mismatched uracil DNA glycosylase (MUG) and human AP endonuclease were
purchased from Trevigen Inc. E. coli uracil DNA glycosylase (UDG) was from U.S.
Biochemical Corp. Adenosine 5'-['y-32P]triphosphate ([V-32P]ATP) was from ICN Life
Sciences. Sephadex G-50 quick spin columns were purchased from Roche Applied
Science. Urea-15N (98% + 15N-enriched) was obtained from Cambridge Isotope
Laboratories. All other chemicals were obtained from Aldrich Chemical Co.
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Synthesis of 5-Chloro-2’-deoxyuridine. Deoxyuridine was chlorinated by the
method of Van Aerschot et al. (19). Deoxyuridine (3 g, 13 mmol) was dried three times
by coevaporation with 25 mL of pyridine and then dissolved in 75 mL of pyridine. Acetic
anhydride (15 mL) was added and the reaction mixture was stirred for 2 h at room
temperature. The progress of reaction was monitored by silica gel thin-layer
chromatography (TLC) in 10% methanol in dichloromethane (CH2CI2). When TLC
analysis showed no starting material, the solvent was evaporated under reduced pressure
and the residue was evaporated twice in ethanol. The residue was then dissolved in
CH2CI2, washed with saturated sodium bicarbonate (NaHCOs) twice, and then dried over
sodium sulfate. Solvents were evaporated and the residue was dried by coevaporation
with 50 mL of pyridine twice. The residue was dissolved in 100 mL of pyridine, and Nchlorosuccinimide (2.5 g, 1.5 equiv) was added. The reaction mixture was stirred for 30
min at 100 °C. TLC analysis with 40% ethyl acetate/ CH2CI2 showed no starting material.
The solvent was evaporated, and the residue was dissolved in CH2CI2 and washed with
saturated NaHCOs twice. The organic phase was evaporated. The residue was dissolved
in NHs/EtOH, and the reaction mixture was stirred for 72 h to remove acetylated groups.
Silica gel purification with a methanol gradient in dichloromethane yielded 3 g (87%) of
CldU.
Synthesis of S-Chloro^’-deoxyJljS-^Njuridine. We previously reported the
synthesis of 15N-enriched deoxyuridine (20). Briefly, uracil was prepared by the method
of Harada and Suzuki using 15N-enriched urea (21, 22). Labeled uracil was converted to
uridine using the method of Vorbruggen and Bennua (23). Labeled uridine was
converted to 2’-deoxyuridine by the method of Robins et al. (24). 2’-deoxy[l,3-
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Nijuridine (300 mg, 1.3 mmol) was converted to 5-chloro-2,-deoxy[l,3- N2]uridine in
the same manner as described above for the unlabeled analogue with an isolated yield of
62%.
Synthesis of 04-ethyl-5-chloro-2’-deoxyuridine Phosphoramidite (Figure 2).
CldU was converted to 04-ethyl-5-chloro-2,-deoxyuridine as described previously for
04-ethyl-5-fluoro-2,-deoxyuridine (18). CldU was acetylated in pyridine with acetic
anhydride. CldU (1.02 g, 3.9 mmol) was dried twice by evaporation of dry pyridine and
resuspended in 20 mL of pyridine. Acetic anhydride (2 mL, 5 equiv) was added
dropwise. The progress of the reaction was monitored by silica gel TLC in 10%
methanol in CH2C12. After the reaction had proceeded for 90 min at room temperature,
the solvents were evaporated under reduced pressure. The contents were washed in 20
mL of toluene 3 times and dried to a white powder. The yield was 1.45 g (quantitative
conversion), and the acetylated derivative was used without further purification.
The 3’,5’-diacetyl-5-chloro^’-deoxyuridine was converted to 3’,5,-diacetyl-4triazolo-S-chloro^’deoxyuridine by the method of Divakar and Reese (25, 26). To 25 mL
dry acetonitrile in an ice bath were added 2.42 g (9 equiv) of 1,2,4 triazole and 0.73 mL
(2 equiv) of phosphoryl chloride. Triethylamine (4.68 mL, 8.6 equiv) was then added
dropwise. The acetylated derivative (dissolved in 20 mL of acetonitrile) was added
dropwise over a period of 3 min to the solution containing the triazole reagent. The
reaction was monitored by silica gel TLC in 30% ethyl acetate in dichloromethane. After
45 minutes, the reaction was quenched with the addition of 3.27 ml (6 equiv) of
triethylamine and 0.84 mL (12 equiv) of water. The solvents were evaporated under
reduced pressure. The 4-triazole intermediate was used without further purification.
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The 3,,5,-diacetyl-4-triazolo-5-chloro-2,-deoxyurdine derivative was converted to
04-ethyl-5-chloro-2'-deoxyuridine with sodium ethoxide in ethanol. Displacement of the
4-triazole group occurred immediately, but deprotection of the sugar required stirring at
room temperature for 30 minutes. Glacial acetic acid/ethanol at a 1:2 ratio was used to
adjust the solution pH to less than pH 6. Sodium acetate precipitate was filtered with a
Buchner funnel. The solvent was removed under reduced pressure. The product was
precipitated with ethyl acetate and purified by silica gel chromatography with 5%
methanol in CH2CI2. The amount obtained was 0.984 g, representing a yield of 87%

from CldU. ‘HNMR (DMSO-rf<) ppm: 8.55 (1H, s, H6), 6.06 (1H, dd, HI’), 5.26 (1H, d.
3’OH), 5.21 (1H, dd, 5’OH), 4.37 (2H, q, 0-CH2-CH3), 4.23 (1H, m, H3’), 3.84 (1H, m,
H4’), 3.67 (1H, m, H5’), 3.59 (1H, m, H5”), 2.25 (1H, m, H2’H2”), 2.09 (1H, m,
H2’H2”), 1.32 (3H, t, 0-CH2-CH3). ESI/MS data: M+H was calculated as 290.1 m/z, and
found to be 289.8 m/z.
04-Ethyl-5-chloro-2'-deoxyuridine was converted to the S’-O^dimethoxytritylG’0-(2-cyanoethyl)N,N-diisopropylphosphoramidite by established methods (27). The 4ethoxy-5-chloro-2,-deoxyuridine was synthesized into oligonucleotides and was
quantitatively converted to 5-chloro-2’-deoxycytidine during deprotection of the
oligonucleotide in ethanolic ammonia (Figure 2).
Synthesis and Purification of the Synthetic Oligonucleotide. The “CldC
phosphoramidite” (0.1 g) was dissolved in 1 mL of dry acetonitrile and added to the extra
port X of the Pharmacia gene assembler oligonucleotide synthesizer. The normal
synthesis cycle was used for the normal phosphoramidites, but the “CldC
phosphoramidite” cycle was modified by increasing the coupling time by 10 min in order
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Figure 2. Scheme for synthesis. Synthetic pathway for preparation of oligonucleotides
containing 5-Cl-cytosine. Briefly, deoxyuridine is converted to 5-chloro-2,-deoxyuridine
in high yield by the method of Van Aerschot and converted to the 04-ethyl-5'dimethoxytrityl-3'-phosphoramidite as described previously for 5-fluoro-2,-deoxyuridine.
The amino group of C1C is added during oligonucleotide deprotection in ethanolic
ammonia
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to improve the efficiency of coupling. These cycles were used to prepare
oligonucleotides of the following sequences:
strand A: 5’d( C A G clC C )
strand B:5’d(GGCTATCGTGGCclCGGCCACGACGG)
strand C:5’ d(TCAGATTCGCGCclCGGCTGCGATAAGCT)
strand D:5’d(AGCTTATCGCAGCclCGGCGCGAATCTGA)

Following synthesis, each resin was deprotected in ethanolic ammonia (prepared by
flowing ammonia gas through ethanol for 1 hour at 0°C) and heated at 60°C overnight in
a sealed vial. Following deprotection, the oligonucleotides were filtered through an
Acrodisc syringe filter (25mm, 0.45pm) in order to filter excess CFG beads. The
oligonucleotides were then purified with Poly-Pak II cartridges (Glen Research),
according to the manufacturer’s instructions. The oligonucleotides were characterized by
electrospray mass spectrometry, GC/MS following acid hydrolysis and conversion to the
trimethylsilyl ethers, and HPLC/ESI/MS analysis following enzymatic hydrolysis with
nuclease PI followed by bacterial alkaline phosphatase.
Electrospray Ionization-Mass Spectrometry. Full mass scanning and low
energy collisionally induced dissociation (CID) were carried out on a ThermoFinnigan
LCQ Deca XP with an electrospray ionization unit. The oligonucleotides were dissolved
in HPLC grade water at 34 pg/mL (1 OD/mL) and directly injected into the ESI/MS
detector at a flow rate of 5 pL/min. The electrospray needle voltage, sheath gas flow rate,
auxiliary gas flow rate, capillary temperature, and other settings were set by autotuning
the mass spectrometer to the peak of the M' peak of the oligonucleotide. In the case of
the 5mer, electrospray needle voltage was held at 3510 V, sheath gas flow rate at 79.49
psi, auxiliary gas flow rate at 19.28 psi, and capillary temperature at 300°C. Helium was
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used as a damping gas and collision activation partner. The collision energy was varied
by changing the resonance excitation RF voltage. In full scan mode (m/z 150-2000), the
injection time was 50 ms with three microscans for obtaining a single scan. Ten scans
were signal averaged for each full mass spectrum scan. The nomenclature for
oligonucleotide fragment ions proposed by McLuckey et al. (28) was used to identify
ions and ion series of sequence relevance. Beginning at the 5’-terminus (3’-terminus), a-,
b-, c-, and d- ions (z-, y-, x-, and w- ions) are produced upon fragmentation at the
different positions of the phosphodiester backbone (Figure 3). The first fragmentation
step is usually the elimination of a nucleobase, followed by cleavage of the 3’phosphodiester bond of the nucleotide that suffered the base loss. Under low-energy CID
conditions fragments of the [an - Bn]' (- B indicating loss of the nucleobase) and w-ions
are the predominant types of fragments (29).
HPLC/ESI/MS. Strand A (0.17 mg) was incubated with 5 pg of nuclease PI in
0.02 M sodium acetate buffer (pH 4.8) for 2.5 hours at 37°C. Then, 2.5 units of bacterial
alkaline phosphatase were added with a 10X 1 M Tris-HCl buffer (pH 7.5) for a final
concentration of 0.1 M Tris-HCl buffer. This reaction mixture was incubated overnight
at 37°C. Samples (10 /T.) were injected from a Thermofinnigan Surveyor autosampler
coupled to a Thermofinnigan Surveyor LC pump. A ThermoHypersil-Keystone Aquasil
C-18 column (150 * 2.1 mm; 3 pm particle size) was used with methanol/water/1%
trifluoroacetic acid (1:89:10 v/v/v) as carrier solvent. The LC pump was connected to a
Thermofinnigan Surveyor photodiode array and then interfaced to the Thermofinnigan
LCQ Deca XP electrospray ionization mass spectrometer. The mass spectrometer was
tuned for maximum gain for deoxynucleosides. The electrospray needle voltage was set
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Figure 3. Scheme for nomenclature for oligonucleotide fragment ions by tandem MS
upon CID of multiply charged precursor ion. Charges are omitted in the structures.
Under low-energy CID conditions, fragments of the a-B- and w-ions are the predominant
types of fragments.
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to 5000 V, sheath gas at 35 psi, auxiliary gas at 0 psi, and capillary temperature to 275°C.
In the full scan mode (m/z 150-1000), the injection time and microscans were set at 100
ms and 3 microscans for each scan. Ten scans were signal-averaged for the full mass
spectrum scan.
Glycosylase Assay. Strand B and similar strands with the exact same sequence
but with CldU and dU substituted instead of CldC were labeled on the 5’ end with P
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using [y- P]ATP and T4 polynucleotide kinase under conditions recommended by the
enzyme supplier. Labeled mixtures were then centrifuged through a G-50 Sephadex
column to remove excess unincorporated nucleotide. Labeled single strands were then
annealed to their complementary strands with the base of interest paired with dG or dA.
The annealing was carried out at a 2:1 ratio (complementary strand:CldC strand).
Annealing mixtures were heated to 95°C for 5 minutes and then cooled slowly to room
temperature. The mixtures (approximately 4 pmol/reaction) were then probed with MUG
and UDG to detect cleavage by glycosylases with the chlorinated base opposite guanine
or adenine. UDG assays were done with 1 /'L of UDG (1 unit/^L) for 20 min at 37 ° C in
50 mM HEPES-KOH, pH 7.4, 10 mM NaCl, 1 mM EDTA, and 1 mM DTT. MUG assays
had 1 /C of MUG (1 unitM.) for 20 min at 37 3 C in 20 mM Tris-HCl, pH 8.0, 0.1
mg/mL BSA, 1 mM EDTA, 1 mM [ethylenebis(oxyethylenenitrilo)]tetraacetic acid
(EGTA), and 1 mM DTT. The apyrimidinic sites were cleaved with 1 unit of AP
endonuclease incubated at 37 ° C for 1 h. The reactions were quenched with MaxamGilbert loading buffer (98% formamide, 0.01M EDTA, 1 mg/mL xylene cyanol, and 1
mg/mL bromophenol blue) and electrophoresed on 18% denaturing polyacrylamide gels
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(8 M urea). The results were visualized by use of a Molecular Dynamics
Phosphorlmager.
Gas Chromatography-Mass Spectrometry. GC/MS experiments were
performed on an Agilent technologies 6890N gas chromatograph interfaced with a 5973
mass-selective detector fitted with a series 7683 autosampler/autoinjector. To test
deamination rates in duplex DNA, equimolar amounts of strand C and D were incubated
at 95°C for 5 min and allowed to cool slowly to room temperature over a period of about
3 h. For each sample, the amount of CldC was calculated and an equimolar amount of 5chloro-2'-deoxy[l,3-15N2]uridine was added as an internal standard because previous
studies reported that CldC was quantitatively converted to CldU during the hydrolysis
process (4). Each oligonucleotide sample was hydrolyzed with 60% or 88% formic acid
for various time points from 15 to 180 min at 140 and 150°C in sealed vials. Contents
were dried under reduced pressure and then derivatized with BSTFA w/1% TMCS and
acetonitrile (1:1 v/v) for 30 min at 140 ° C. Injections (2 pL) of the reaction solution
were analyzed in electron impact ionization mode. Injector and detector temperature were
250 and 280°C, respectively. The initial GC temperature was 100 °C for 2 min with a
10°C/min rise up to 180 °C and a final 30 °C/min rise to a final temperature of 260 °C.
GC retention times were ascertained with the injection of authentic compounds, and an
acetonitrile blank was run to ensure that no analytes were remaining on the injector.
Deamination rates were calculated from examination of the integrated areas of the
silylated C1U and 5-chloro-[ 1,3-15N2]uracil (15N2-C1U) peaks obtained at 275 and 277
amu. Theoretical ion abundance profiles were calculated as previously described (30).
The expected M + 2 peak for the silylated C1U derivative was calculated to be 41.27% of
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the parent peak for silylated C1U. We used this value to correct for the influence of the
natural isotope abundance to the silylated 15N2-C1U. The appearance of C1U, derived
from the deamination of C1C, was measured by comparing the integrated area of the
unenriched C1U to the integrated area of the enriched C1U internal standard. Rate
constants for the appearance of C1U were calculated by fitting the data to the first-order
rate equation:

C, = (Co - C.)(1 - e<'kt>)

(Equation 2)

where t is time (minutes), Ct is the normalized concentration of C1U formed at time t, Co
is the normalized concentration of C1U present at time zero, Coo is the concentration of
C1U extrapolated to infinite time, and k is the rate constant.
Rates for the degradation of C1C were independently calculated by comparing the
C1C peak area to that of the thymine peak area at each time point. In this case, rate
constants were calculated by fitting the data to the first-order rate equation:

Ct — [100 — (Cq-Coo)] + (Co-Coo)e

(-kt)

(Equation 3)

where t is time (minutes), Ct is the normalized concentration of C1C present at time t, Co
is the normalized concentration of C1C remaining at time zero, Coo is the concentration of
C1C extrapolated to infinite time remaining, and k is the rate constant.
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Figure 4. Direct injection of oligomer, 5,-CAGclCC-3’, into ESI/MS at SjoL/min in
negative ion mode. (A) Full Scan. Note both single and double charged parent peaks.
Single charged base fragments are visible. (B) CID mass spectra of 1480.3 ion with 25%
collision energy. Many more fragments with the correct masses are visible. (C) Zoom
scan of 1480.3 ion. Note prominent M+2 peak. (D) Zoom scan of 1028.1 ion. Note loss
of M+2 peak indicating loss of Cl- ion from the a4-b4 fragment which has lost CldC.
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Table 1. Comparative data of ESI/MS direct injection of 5mer, 5’-CAGclCC.
Oligonucleotides were dissolved in water and directly injected into the ESI/MS. Ions
and Ion fragments are identified by characteristic mass spectra.

Characteristic
Ions and Ion
M'
M2'
[35-65]
[34-64]
[83-63]

w4
w3
w2
W-i

Calculated m/z
values

Experimental
m/z values

1480.3
739.6
1369.2
1028.1
699.1
1271.2
958.2
629.1
306.1

1480.3
739.8
1369.1
1028.2
699.1
1271.1
958.1
629.1
306.1
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base, C1C (Figure 4D). Our mass spectral data with the intact oligonucleotide was
consistent with oligonucleotides containing CMC as the predominant product.
To further verify the composition of the oligonucleotides and check for trace
levels of CldU, the deamination product of CMC, we assayed our oligonucleotides with
HPLC/ESI/MS following enzymatic hydrolysis. The chlorinated pyrimidines have
characteristic UV spectra and retention times under these separation conditions (Table 2).
No CldU was observed following enzymatic hydrolysis of the oligonucleotide,
confirming the integrity of the CldC oligonucleotide under these conditions (Figure 5).
Our analytical characterization of the CIC-containing oligonucleotides using (1)
electrospray mass spectrometry of the intact oligonucleotide, (2) HPLC analysis
following enzymatic digest, and (3) GC/MS analysis following 88% formic acid
hydrolysis indicated no measurable formation of C1U or unknown side products during
synthesis. Additionally, we sought a sensitive method for measuring low levels of C1U in
intact oligonucleotides by use of DNA repair enzymes. Previous studies by our group
have shown that 5-chlorouracil is rapidly removed from a 5-chlorouracil-guanine mispair
by mismatch uracil glycosylase (MUG) but not by UDG, the predominant uracil DNAglycosylase in human cells (31). We therefore paired our synthetic CIC-containing
oligonucleotide with a complementary strand containing G opposite C1C (Figure 6).
When compared to the substantial cleavage by MUG of a control ClU-containing
oligonucleotide, only trace (less than 2%) cleavage could be observed with the CICcontaining oligonucleotide (Figure 6). This novel approach to measuring deamination
rates in the intact oligonucleotide avoids the uncertainty involved with potential chemical
reactions of labile nucleosides that can occur during oligonucleotide hydrolysis.
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Table 2. Analytical LC/ESI/MS data of nucleosides. The oligonucleotides were
enzymatically hydrolyzed to generate constituent free nucleosides, which were
subsequently analyzed by LC/ESI/MS. Nucleosides are identified by their characteristic
retention times, UV spectra, and mass spectra.

Nucleoside

Retention
time (min.)

UV
absorption

Mass Spectra
peaks (m/z)

2’-deoxycytidine

6.56

230, 270

228.0 (M+) ,
455.1, 477.0

5-01-2’deoxycytidine

13.97

230, 285

262.0 (M+),
523.0, 545.0

2’-

15.00

230, 295

252.1 (M+)

16.98

250

268.0 (M+),
535.0, 557.1

thymidine

19.5

225, 265

242.9 (M+),
265.1,484.9,

5-CI-2’deoxyuridine

19.5

230, 275

285.0 (M+),
420.9, 422.9

deoxyadenosine
2’-

deoxyguanosine
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Figure 5. LC/ESI/MS analysis of oligonucleotide, 5,-CAGclCC-3’ after enzymatic digest.
(A) Total photodiode array chromatogram at 200 - 350 nm. Note the lack of a peak
corresponding to CldU. (B)Mass Spectrum of 5-Chloro-2’-deoxycytidine using LC/MS
in positive ion mode.
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Figure 6. Glycosylase assay. Strand B was labeled and annealed with appropriate strand
to form duplex DNA. The identity of the base pair at the cleavage site is indicated in the
figure. (A) MUG assays. The reactions were performed at 37°C for 20 min. with 1 unit
of MUG. (B) UDG assays. The reactions were performed at 37°C for 20 min. with 1 unit
of UDG. The apyrimidinic sites of both assays were cleaved with lunit of AP
Endonuclease incubated at 37°C for 1 hour.
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Experiments with CIC-containing oligonucleotides in HeLa cell nuclear extract failed to
reveal substantial repair activity targeted against C1C (data not shown).
Recent studies directed toward measuring C1C in DNA have assumed that the
deamination of C1C to C1U is complete prior to analysis by GC/MS. Using our synthetic
oligonucleotides, we wished to determine conditions under which C1C could be measured
directly by GC/MS methods. We observe that C1C does silate well, and two species are
observed by GC/MS containing two or three TMS groups consistent with theoretical
mass spectra (Figure 7C). We then reexamined some conditions used to chemically
hydrolyze oligonucleotides prior to derivatization and GC/MS analysis (4). We observed
that acid hydrolysis for 90 min with 60% formic acid at 150°C did not completely
deaminate the C1C from the oligonucleotides (Figure 7A). Indeed, approximately 25% of
the original C1C still remained unchanged even under these conditions, and 5% remained
after 3 h. We further observed that, on a molar basis, the amount of C1U formed was less
than the amount of C1C lost, indicating at least two pathways for the destruction of C1C
under hydrolysis conditions (Figure 8). The hydrolysis of the synthetic oligonucleotides
was also investigated by use of 88% formic acid at 140°C, standard conditions for
oligonucleotide hydrolysis for our laboratory.
The rate constant for the appearance of C1U was found to be 0.0079 min'1 at
140°C, 88% formic acid, and 0.0044 min'1 at 150°C, 60% formic acid. The rate constant
for the disappearance of C1C was found to be 0.0150 min'1 at 140°C, 88% formic acid,
and 0.0210 min'1 at 150°C, 60% formic acid. In both cases, the rate of C1C disappearance
was greater than the rate of C1U appearance, indicating that C1C degradation involves
more than simple deamination under these hydrolysis conditions.
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Figure 7. GC/MS analysis of duplex DNA of strands C and D. Total Ion chromatogram
of duplex DNA after 90 min of 60% formic acid hydrolysis at 150°C. Mass Spectra of
major ions of silylated C1C and 15N2-C1U (inserts).
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Figure 8. Deamination rates of C1C in duplex DNA. Percent C1C (%C1C) remaining and
Percent C1U (%C1U) formed vs. time for duplex DNA of strands C and D at conditions
shown. Error bars are equal to 1 standard deviation and there are 3 samples for each data
point. Co is assumed to be 100%. (Cq-Coo) and k values were calculated by fitting the
data points to equations 2 and 3.
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F. Discussion
The 5-halopyrimidines, including C1C, are now established DNA damage
products, the formation of which increases substantially with host inflammation
responses (3-7, 13,14). Our primary interest in developing a synthetic method for the
preparation of CIC-containing oligonucleotides was to provide substrates for subsequent
biophysical and biochemical studies aimed at understanding the biological consequences
of chlorinated pyrimidines in DNA. The method reported here is simple and efficient and
accomplishes this initial goal.
By this method, oligonucleotides can be constructed with C1C residues at selected
positions. Oligonucleotides with verified amounts of C1C were used to investigate
methods employed for analysis of damaged bases by GC/MS methods. We observe that
C1C does not deaminate completely during hydrolysis, and under conditions standard for
our laboratory, only 25% loss is observed. Our results demonstrate that, under conditions
used by other laboratories for oligonucleotide hydrolysis, the deamination of C1C is not
complete, and considerable destruction of C1C occurs.
A significant challenge in the analysis of damaged bases in DNA is that
artifactual changes can occur in the process of converting the oligonucleotide to its
constituent monomers for subsequent analysis. As demonstrated here, mass spectral
methods can be used to confirm the composition of the predominant product from
chemical synthesis, but these methods cannot identify trace amounts of impurities that
might be present. Our primary concern with the preparation of the CldC-containing
oligonucleotides was the potential formation of C1U by either hydrolysis during synthesis
or deamination following synthesis. Previously, we demonstrated that C1U residues in
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oligonucleotides were very good substrates for a class of uracil-DNA glycosylases that
repair mispaired uracil and 5-substituted uracil residues (31). The chlorination of a
cytosine residue in DNA, followed by deamination, would generate a C1U-G mispair and
therefore be a substrate for glycosylase repair.
We therefore prepared substrates containing both C1C and C1U and formed
duplexes with a complementary strand containing G opposite the chlorinated pyrimidine.
As shown in Figure 6, the oligonucleotide containing the C1U residue mispaired with G is
efficiently cleaved by MUG. Under the same conditions, only a trace amount of cleavage
is observed with the CIC-containing oligonucleotide. At this time, we cannot rule out that
this can be due to a weak activity of MUG against the C1C-G pair. More likely, the
activity is due to a trace amount of deamination forming a C1U-G pair. In either case, we
know that the oligonucleotide containing C1C is better than 98% pure containing C1C by
this sensitive assay. This method can also be used to purge oligonucleotides of the C1U-G
mispair for future DNA polymerase fidelity studies.
The selectivity of the glycosylases in the base excision repair pathway for
damaged pyrimidines is based upon the size of the 5-substituent, the presence of specific
functional groups, and the base present in the opposing DNA strand (31). The primary
uracil glycosylase in human cells, UDG, has a tight binding pocket that excludes the
larger chlorine atom (31-33). Although MUG can accommodate the larger halogen, it will
remove the modified pyrimidine selectively when it is mispaired with guanine. In DNA,
mispairs between T and G can form by misincorporation during DNA replication or by
deamination of 5-methylcytosine. Although the active-site pocket of MUG can
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accommodate the thymine methyl group, and even the larger 5-iodo substituent, it does
not remove thymine (31).
Previously we argued that the discrimination against T was based upon electronic
effects, as opposed to substituent size (31). Electron-withdrawing substituents in the 5position destabilize a base to spontaneous hydrolysis and make the base a better substrate
for glycosylases (34, 35). Bianchet et al. (36) have demonstrated that the uracil base in
the active site of UDG is ionized in the N1 position at physiological pH. Presumably, the
5-halo substituents could also render a base more susceptible to glycosylase-mediated
cleavage. Consistent with this argument, C1U is rapidly removed. The initial reaction
between cytosine and chlorinating species would form a dihydro intermediate prone to
deamination. Dehydration of the corresponding cytosine and uracil intermediates would
yield C1C and C1U, respectively (Figure 1). The dihydro intermediate could deaminate
and then dehydrate in DNA, forming a C1U-G mispair. If replicated prior to repair, C1U
would predominantly pair with adenine, as with 5-fluorouracil and 5-bromouracil (37,
38). Also, C1U accumulation in DNA has been shown to induce sister chromatid
exchanges and mutations (39, 40). However, because of the presence of multiple uracil
glycosylase activities in human cells, C1U mispaired with G would not be a persistent
lesion and should be rapidly repaired (41).
In contrast, C1C may be a persistent lesion in DNA, as it is not a substrate for any
of the uracil glycosylases yet examined, and it is unlikely to be a substrate for most of the
other known glycosylases. Experiments with CIC-containing oligonucleotides in HeLa
cell nuclear extract failed to reveal substantial repair activity targeted against C1C.
Additionally, C1C appears to be resistant to further oxidation by oxidants such as
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peroxynitrite in vitro and may be more stable than other oxidized or chlorinated DNA
base products such as 8-hydroxyguanine, 5-hydroxycytosine, 8-chloroadenine, and 2hydroxyadenine (42). The coding potential of C1C is predicted to be similar to that of C,
and therefore, C1C is unlikely to be a miscoding lesion. However, several sequencespecific DNA binding proteins in human cells are sensitive to the presence or absence of
a methyl group in the 5-position of cytosine. The precise position of 5-methylcytosine
residues in human DNA establishes a methylation pattern that is carefully controlled
through cellular development and differentiation and is often observed to be perturbed in
tumor cells (43-48). The formation of C1C in DNA may therefore interfere with normal
epigenetic patterning. Studies are currently in progress to examine the impact of C1C on
DNA structure and DNA-protein interactions. As C1C is a product of inflammation and is
likely to be a persistent lesion, the presence of C1C in DNA may be an important marker
for prior tissue inflammation.
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A. Abstract
Inflammation-mediated, neutrophil-derived hypochlorous acid, can damage DNA
and result in the chlorination damage products 5-chlorocytosine and 5-chlorouracil as
well as the oxidation damage products 5-hydroxycytosine and 5-hydroxyuracil. While 5chlorocytosine could potentially perturb epigenetic signals if formed at a CpG
dinucleotide, the remaining products are miscoding and could result in transition
mutations. In this paper, we have investigated the reaction of hypochlorous acid with an
oligonucleotide site-specifically enriched with 15N to probe the reactivity of cytosine at
CpG. These experiments demonstrate directly the formation of 5-chlorocytosine at a
CpG dinucleotide in duplex DNA. We observe that chlorination relative to oxidation
damage is greater at CpG by a factor of approximately two, whereas similar amounts of
5-chlorocytosine and 5-hydroxycytosine are formed at two non-CpG sites examined. The
relative amounts of deamination of the cytosine to uracil derivatives are similar at CpG
and non-CpG sites. Overall, we observe that the reactivity of cytosine at CpG and nonCpG sites toward hypochlorous acid induced damage is similar (5-chlorocytosine > 5hydroxycytosine > 5-hydroxyuracil > 5-chlorouracil), with a greater proportion of
chlorination damage at CpG sites. These results are in accord with the potential of
inflammation-mediated DNA damage to both induce transition mutations and to perturb
epigenetic signals.
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B. Abbreviations
MPO: myeloperoxidase, HOC1: hypochlorous acid, HOBr: hypobromous acid,
dC: 2'-deoxycytidine, CldC: 5-chloro-2'-deoxycytidine, CldU: S-chloro^'-deoxyuridine,
HOdC; 5-hydroxy-2'-deoxycytidine, HOdU: 5-hydroxy-2'-deoxyuridine, C1C: 5chlorocytosine, C1U: 5-chlorouracil, HOC: 5-hydroxycytosine, HOU: 5-hydroxyuracil,
BrU: 5-bromouracil, GC/MS: gas-chromatography/mass spectrometry, 5mC: 5methylcytosine, TBDMS: tert-butyldimethylsilyl, MTBSTFA: N-methyl-N-(ter/butyldimethylsilyl)trifluoroacetamide
C. Introduction
Purine and pyrimidine bases in the DNA of all organisms are continuously
damaged by hydrolysis, oxidation, and alkylation under normal physiological conditions
(1,2). The level of damage can increase substantially due to chemical and biological
stress. Reactive molecules associated with inflammation, including the hypohalous acids,
are recognized increasingly as additional and potentially important contributors to DNA
damage (3-19).
The hypohalous acids, HOC1 and HOBr, derived from activated neutrophils and
eosinophils respectively, are known to react with DNA resulting in an array of damage.
Among the potential damage products are 5-hydroxycytosine (HOC) and 5chlorocytosine (C1C) as well as the corresponding deamination products 5-hydroxyuracil
(HOU) and 5-chlorouracil (C1U). Among these, the formation of HOC, HOU and C1U
could lead to miscoding, base misincorporation, and mutation if unrepaired prior to DNA
replication (17-28). In contrast, C1C would not be expected to be miscoding; however,
the formation of C1C in the CpG dinucleotide could perturb epigenetic patterns in DNA

64

by causing inappropriate methyltransferase-mediated cytosine methylation and by
increasing the binding affinity of methyl-binding proteins involved in subsequent histone
modification and chromosome condensation (17-19). Disruptions of epigenetic patterns
are reported in numerous human tumors and are considered critical for understanding
cancer etiology (29,30).
The biological consequences of cytosine damage depend upon the product formed
and the base sequence in which the damage occurs. Sensitive and specific methods have
been developed to identify this series of cytosine damage products. However, these
methods require enzymatic or acid hydrolysis of DNA to the corresponding
deoxynucleosides or free bases, resulting in the loss of information on the sequencedependence of cytosine damage. Central to understanding the impact of HOCl-mediated
damage on epigenetic patterns is information on the reactivity of cytosine in a CpG
dinucleotide in duplex DNA. In order to probe the reactivity of a specific cytosine
residue, we have adopted an approach referred to by our group and others as mass
tagging (31-35). In this approach, individual residues can be distinguished by increasing
their mass with stable isotopes. As the corresponding reaction products would also be
isotopically enriched, the sequence-dependence of reactivity can be assessed using
standard mass spectrometry methods.
In this paper, we have constructed an oligonucleotide duplex containing a target
CpG dinucleotide in which the non-target cytosine residues have been enriched with 15N.
This oligonucleotide was reacted with HOC1, hydrolyzed, and analyzed by gaschromatography/mass spectrometry (GC/MS). Results confirm the formation of the
expected products HOC, HOU, C1C and C1U; however, the relative formation of the
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chlorination and oxidation damage products is different at a CpG dinucleotide compared
with other cytosine residues in the molecule. This study provides direct evidence for the
formation of C1C at a CpG dinucleotide, consistent with our proposal that inflammationmediated reactive molecules could result in epigenetic changes frequently seen in human
tumors.
D. Material and Methods
The phosphoramidites of the normal DNA bases and Poly-Pak II cartridges were
obtained from Glen Research. N-methyl-N-(tcr/-butyldimethylsilyl)trifluoroacetamide
supplemented with 1% fer/-butyldimethylchlorosilane (MTBSTFA with 1%TBDMCS)
was purchased from Pierce. Urea-15N (98% + 15N-enriched) was obtained from
Cambridge Isotope Laboratories. Chelex-100 resin was purchased from Bio-Rad.
Oligonucleotide Synthesis and Characterization. Standard phosphoramidites
and oligonucleotide synthesis reagents (36) were obtained from Glen Research.
Synthesis was preformed with a Pharmacia Gen Assembler. Enriched (15N3) 2'deoxycytidine (dC) was prepared as previously described (37). Enriched dC was
converted to the 5'-dimethoxytrityl-3'-cyanoethylphosphoramidite as previously
described (38). Standard synthetic conditions were utilized for the incorporation of the
enriched dC phosphoramidite into the oligonucleotide. Following synthesis,
oligonucleotides were deprotected and released from the resin by treatment with
concentrated aqueous ammonia at 60 C overnight. Purification utilized Poly-Pak II
cartridges. Base composition was confirmed by acid hydrolysis and analysis of the
corresponding tert-butyldimethylsilyl ethers by GC/MS (39).
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Reaction of HOC1 with an Oligonucleotide Duplex. Standard and isotopicallyenriched oligonucleotides were reacted with HOC1 in buffered solution. All solutions
were treated with Chelex-100 resin before use. HOC1 concentration was quantified
spectrophotometrically at 290 nm (pH 12, e = 350 M'1 cm'1) immediately prior to
reaction (40). In a standard reaction, 55 nmol of oligonucleotide in 400 uL (137.5 pM) of
50 mM sodium phosphate buffer (pH=7.4) was incubated with 0-200 nmol of HOC1 (0500 pM) for specified periods of time at 37 C. The reaction was quenched with addition
of excess ice cold L-Methionine. The samples were then dialyzed against water for over
18 hours. Following dialysis, solvent was removed under reduced pressure.
Oligonucleotides were hydrolyzed with 200pL 88% formic acid in sealed vials at 140 C
for 30 min. Formic acid was evaporated under reduced pressure, and the samples were
derivatized with 200 pL MTBSTFA (1%TBDMCS) /acetonitrile (1:1, v/v) at 140 C for
30 min.
GC/MS Analysis of Damaged Bases. GC/MS analysis was conducted in
electron impact (El) mode with an Agilent 6890 GC containing an HP-5ms column
(dimensions 30 m x 0.25 mm x 0.25 pm) interfaced directly to a 5973 inert massselective detector fitted with a series 7683B autosampler/ autoinjector. Injector and
interface temperature were 250°C and 280°C, respectively. The initial GC temperature
was 100°C for 2 min with a 10°C min'1 increase up to 230°C and a final 30°C min'1 rise to
a final temperature of 260°C. El source temperature was 230°C and quadrupole
temperature was 150°C, with electron energy at 70 eV. Helium gas, obtained from
Gilmore (El Monte, CA) was research grade. A volume of 1 uL was injected in split
mode (20:1). Data were collected in scan or selected ion mode, depending upon the
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specific experiment. Standards of HOdC, HOdU, CMC and CldU were prepared and
characterized as previously described (41). The internal standard 5-bromouracil was
obtained from Sigma and used to prepare calibration curves.
Deamination of cytosine and cytosine damage products can occur during
oligonucleotide hydrolysis and derivatization. While silylation with BSTFA containing
1% TMCS (resulting in the trimethylsilyl derivatives) results in significant deamination
(42), we have observed that the silylation reported here with MTBSTFA containing 1%
TBDMCS results in substantially less deamination, perhaps because the steric bulk
surrounding the derivatized 4-amino group inhibits subsequent deamination. In control
experiments using the latter, the conversion of CMC to C1U from acid hydrolysis and
derivatization never exceeded 2%, and the conversion of HOdC to HOU was often
undetectable and never exceeded 1%.
Quantitation of Damaged Bases with Overlapping Mass Spectra. In
experiments with isotopically enriched pyrimidines, the enrichment with 2 or 3 15N atoms
is not sufficient to achieve complete separation of the mass spectra of the unenriched and
enriched species. To correct for overlap, the relative intensities of the isotope lines in the
mass spectra of the unlabeled (lighter) derivatives were calculated based upon the
molecular formula of a specific ion. The theoretical peak intensities in the isotope cluster
of the M-57 peak for derivatized cytosine (CnF^NsOS^) are 73.1% (282 Da), 18.4%
(283 Da), 7.1% (284 Da), 1.2% (285 Da), and 0.2% (286 Da). The theoretical and
experimental isotope clusters agree, routinely within 2%.
Enrichment of cytosine with 15N in all three nitrogen positions increases the mass
by 3 Da and shifts the corresponding isotope cluster 3 Da to heavier mass. When
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examining a mixture of the unenriched cytosine derivative (282 Da) and 15N3-enriched
cytosine (285 Da), the mass spectra of the two isotopomers will partially overlap. The
peak at 282 Da arises from the unenriched isotopomer exclusively. Characterization of
15N3dC used for phosphoramidite synthesis showed the percentage of the unenriched
isotopomer (282 Da) to the enriched isotopomer (285 Da) to be 0.013%. Therefore, the
enriched analog contributes negligibly to the 282 Da peak. However, the peak at 285 Da
contains contributions predominantly from the 15N3-cytosine enriched isotopomer and
heavier isotopes of C, H, N, O and Si at natural abundance from the unenriched cytosine.
The contribution from unenriched cytosine to the 285 Da peak from heavier isotopes at
natural abundance is 1.6 % of the 282 Da peak.
In a similar manner, overlapping contributions can be determined for the cytosine
damage products. The contribution of the unenriched isotopomer of HOC (412 Da) to
the 415 peak is 4.1%. The contribution of the unenriched isotopomer of C1C (316 Da) to
the 319 peak is 9.7%. The greater overlap in the chlorinated species results from the
presence of chlorine isotopes at 35 Da (75.53%) and 37 Da (24.47%). The overlap for
the deaminated derivatives, HOU and C1U is greater than the corresponding cytosine
derivatives because the 15N at the 4-position is lost during deamination. The contribution
of the unenriched isotopomer of HOU (413 Da) to the 415 peak is 17%, and the
contribution of the unenriched isotopomer of C1U (317 Da) to the 319 peak is 42.3 %.
In the design of the experiments reported here, the target CpG could have been
enriched, as opposed to enrichment of the non-CpG sites. However, the primary
objective was to provide direct evidence for damage at the CpG site. By labeling the
non-CpG sites, the masses of the corresponding damage products would be shifted to
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higher mass, allowing direct examination of the products generated at the unenriched
CpG site without requiring correction for overlapping isotopes.
While the spectra of the unenriched derivatives reported here overlap partially
with the enriched derivatives, requiring correction in order to determine the amounts of
the enriched derivatives, the experiments reported here utilize a common synthetic
oligonucleotide in which the ratio of enriched to unenriched parent cytosine is constant.
Therefore, comparison of the relative amounts of enriched and unenriched cytosine
damage products provides a reliable indicator of the relative reactivity of cytosine at the
CpG position relative to the non-CpG sites, independent of quantitation based upon use
of the 5-bromouracil internal standard.
E. Results
A 2'-deoxycytidine analog enriched with 15N in the N(l) and N(3) ring positions
was prepared and site-specifically incorporated into a self-complementary 12mer
oligonucleotide as shown in Figure 9. Oligonucleotide deprotection in 15N-enriched
ammonium hydroxide results in additional 15N-enrichment at N(4) amino position. The
self-complementary 12mer oligonucleotide examined here showed typical UV-dependent
changes in the UV spectrum as shown in Figure 10. Unlabeled oligonucleotide (13.75
nmol) was dissolved in 100 pL of 50 mM sodium phosphate buffer (pH = 7.4) to a
concentration of 137.5 jiM . The observed melting temperature of the oligonucleotide,
50°C, is close to the value of 51.3 C predicted for this sequence using the online
prediction tool, HyTher™ server (Department of Chemistry, Wayne State University).
This self-complementary oligonucleotide would be predominantly in a duplex at and
o

below physiological temperature (37 C).
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Figure 9. Oligonucleotide sequence and structure of 15Ns 2'-deoxycytidine used in this
study. The cytosine residues at position 1 and 5 (bold italic) have been isotopically
enriched. The unenriched cytosine residue at the 6 position (CpG) gives rise to damage
products C1C, C1U, HOC, and HOU whereas the enriched cytosine residues at positions 1
and 5 give rise to isotopically enriched products of higher mass. The mass of the
predominant ion used for measurement of the damage product is shown in the figure.
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Figure 10. Melting temperature study for oligonucleotide shown in figure 9. Unlabeled
oligonucleotide (13.75 nmol) was dissolved in 100 pL of 50 mM Sodium phosphate
buffer (pH = 7.4) to a concentration of 137.5 pM. Data were collected at 0.5 °C
intervals. The Tm of duplex was determined using the hyperchromicity method of Cary
Win UV Thermal software (Varian) with the average of 3 independent Tm
measurements.
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Preliminary experiments were conducted with an unenriched oligonucleotide
containing only standard, unenriched bases. The unenriched oligonucleotide was
incubated with increasing concentrations of HOC1 for 60 min. Base composition analysis
by GC/MS following formic acid hydrolysis and silylation with MTBSTFA/TBDMCS
revealed the presence of several peaks not observed in the untreated oligonucleotide
(Figure 11). The damaged bases giving rise to the observed additional peaks were
identified as C1C, HOC, HOU and C1U on the basis of characteristic retention times and
mass spectra. The predominant ion in the mass spectra for each of these compounds is
the M-57 peak resulting from loss of a tert-butyl group as shown in Figure 12. The
isotope cluster of the silylated HOC and HOU (Figure 12C, D) show a typical pattern for
molecules of this size in that the monoisotopic line is the highest intensity, and the
corresponding lines at higher mass resulting from enrichment of heavier isotopes of C, H,
N, O and Si at natural abundance progressively decrease in size. In contrast, the isotope
cluster for C1C and C1U show a typical pattern for a chlorine-containing molecule of this
size in that the M+2 peak is larger than the M+l peak (Figure 12 A, B).
Calibration curves were constructed relating peak area to base concentration using
5-bromouracil as the internal standard. Peak areas for a selected ion were then used to
determine the amount of each of the modified bases, as well as the precursor cytosine, in
each sample. The amount of each of the modified bases formed increased with the
concentration of HOC1 present in the incubation mixture (Figure 13). The predominant
products formed are C1C and HOC. The corresponding deamination products HOU and
C1U were minor products in all reactions examined. The relative amounts of the four
reaction products measured did not change significantly with incubation time or HOC1
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Figure 11. Gas chromatograph of C1U, C1C, HOC, and HOU obtained from reacting
unenriched oligonucleotide (137.5 pM) with 500 pM HOC1 at 37°C for 1 hour. Data
were collected with selected ion monitoring for C1U (ion 317), C1C (ion 316), HOC (ion
412), and HOU (ion 413) to obtain the chromatograph.
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concentration. The molar amounts of the four damage products observed are presented in
Table 3.
In order to examine the sequence-dependent reactivity of HOC1 toward cytosine,
the above experiments were repeated with the oligonucleotide containing the enriched
cytosine residues at positions 1 and 5 and unenriched cytosine at the target CpG (position
6, Figure 9). Base analysis by GC/MS following acid hydrolysis of the enriched
oligonucleotide was consistent with the expected composition. Analysis of the cytosine
peak, but no others, revealed the presence of enriched bases. The ratio of unenriched to
enriched cytosine was 2:1 as shown in Figure 14A.
The site-specifically isotopically-enriched oligonucleotide was then reacted with
HOC1 as described above. Following oligonucleotide hydrolysis and GC/MS analysis,
peaks with retention times corresponding to C1C, HOC, C1U and HOU were observed in
scan mode. In Figure 14B, the selected ion chromatogram at 316 and 319 Da,
corresponding to formation of C1C, is shown. The peak at 316 arose from formation of
C1C at the CpG target site (position 6, Figure 9). The peak at 319 Da arose
predominantly from formation of C1C at the two non-CpG sites at Ci and C5.
The mass spectra of the four damage products derived from the enriched
oligonucleotide (Figure 15) are more complicated than those arising from the unenriched
oligonucleotide (Figure 12) due to the presence of both isotopically-enriched and
unenriched species. In each case, the observed mass spectrum results from the partial
overlap of the corresponding mass spectra for the isotopically enriched and unenriched
damaged bases. For the cytosine derivatives, the mass spectral lines arising from the
enriched cytosine at positions 1 and 5 are all increased by three mass units. The lines in
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Table 3. Amounts of cytosine reaction products for both unenriched and enriched
oligonucleotide reacted with 500 pM HOC1 at 37°C for 1 hour. Data are given in nmoles
of product per pmoles of cytosine. Parentheses indicate 1 standard deviation from
triplicate data.
T3Ns -enriched

5Ns -enriched

Unenriched

oligonucleotide

oligonucleotide

oligonucleotide

CpG

non-CpG

Product

(nmol/pmol C)

(nmol/pmol C)

(nmol/pmol C)

C1C

54.7 (3.7)

17.3 (1.5)

21.7(1.7)

HOC

36.7 (0.3)

6.40 (0.5)

21.8(1.6)

C1U

1.40 (0.2)

0.80 (0.09)

1.00 (0.1)

HOU

10.7 (0.2)

2.20 (0.15)

6.00 (0.2)
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Figure 14. Extracted Ion Chromatographs of (A) Ions 282 and 285 for cytosine from
isotopically enriched oligonucleotide incubated in buffer for 1 hr at 37 C (negative
control) and (B) Ions 316 and 319 for C1C from isotopically enriched oligonucleotide
reacted with 500 pM HOC1 for 1 hr at 37 C. Note while the area of Ion 282 appears to be
approximately half the area of Ion 285 indicating a 1 to 2 ratio of species, the area for Ion
316 is a much higher percentage of the area for Ion 319 indicating a larger ratio of the
unenriched species.
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the spectra of the cytosine damage products arising from the unenriched cytosine at
position 6 are not increased in mass and correspond to the lines observed in the spectra of
the unenriched damage products. The lines arising from enriched cytosine for the
deamination products C1U and HOU are shifted by 2 mass units to higher mass. The
conversion of the cytosine to uracil analogs results from the loss of the l5N-enriched N(4)
ammo group.
Because the mass spectra of the enriched and unenriched derivatives are partially
overlapping, the amount of each heavy derivative cannot be obtained directly from
measuring relative peak areas. For example, the 316 line of C1C arises exclusively from
the M-57 ion of unenriched cytosine. However, the 319 line arises predominantly from
the M-57 ion of an enriched (+3) cytosine residue, but has a significant contribution from
the 319 line of the unenriched cytosine residue due to the natural abundance of heavier
isotopes. The relative contribution of isotopes at natural abundance to the peaks within
the isotope cluster can be determined as described in materials and methods and
subtracted from the peaks arising from the isotopically enriched species. Using this
approach, the amounts of each of the four damage products investigated here, derived
from the unenriched target CpG at position 6, could be measured independently of the
enriched cytosines at positions 1 and 5. The results of this experiment are presented in
Table 3.
F. Discussion
The reaction of HOC1 derived from activated neutrophils is known to react with
DNA, forming a spectrum of damage products (3-16). As confirmed here, C1C, HOC,
C1U and HOU are among the damage products formed from cytosine. The biological
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consequences of the formation of each of these adducts are still under investigation.
These damage products could be mutagenic and perturb sequence-specific protein
interactions. Of particular interest is C1C due to its capacity to mimic 5mC in both the
binding of methyl-binding proteins involved in chromatin remodeling and in directing the
methyltransferase-mediated methylation of cytosine in the opposing strand within a CpG
dinucleotide (17-19). The formation and biological significance of the potential cytosine
damage products reported here likely depend upon the local DNA sequence where the
damage occurs. This is particularly true for C1C in that the capacity of C1C to perturb
epigenetic patterns requires its formation in the CpG dinucleotide. A primary objective
of this study therefore was to directly demonstrate the formation of C1C in the CpG
dinucleotide.
Some previous studies have reported on HOC1 damage to cytosine residues in
DNA by measurement of C1U as a surrogate marker (11). In those studies, it was
presumed that the initially formed C1C would deaminate readily to C1U in DNA, and that
deamination would be completed during acid hydrolysis. The C1U derivative formed in
those studies was readily observed by negative chemical ionization MS. Similar analysis
of C1C was not feasible in those studies due to the poor sensitivity for cytosine
derivatives using GC-NCI-MS methods. Studies reported by our laboratory placed 5chlorocytosine into synthetic oligonucleotides and examined recovery following formic
acid hydrolysis under a variety of conditions (42). Contrary to expectation, we observed
that most of the 5-chlorocytosine could be recovered intact and could be analyzed by
electron-impact GC/MS as its trimethylsilyl derivative. In studies reported here, we

89

extend these findings and report that deamination during sample preparation can be
minimized by forming the tert-butyldimethylsilyl derivatives.
In the initial experiment reported here, we examined the reactivity of an
isotopically unenriched oligonucleotide containing normal bases. We observed that the
chlorination and oxidation products of cytosine, C1C and HOC, were the predominant
reaction products (Figure 11 and Table 3). Of the total reaction products, C1C was the
predominant product (53%), followed by HOC (35%), with the corresponding
deamination products approximately 10% (HOU) and 1.4% (C1U). The spectrum of
reaction products was observed to be similar at all concentrations of HOC1 examined
(Figure 13). Previously, it has been demonstrated that activated neutrophils can generate
HOC1 concentrations at a level of several hundred micromolar (43, 44). Furthermore,
chlorinated cytosine residues have been identified in the DNA of tissues exposed to
activated neutrophils (14) indicating that HOC1 released from activated neutrophils can
find its way to cellular DNA. Therefore, the results reported here with our reaction
conditions likely reflect the types of damage products that could occur in cellular DNA,
although the magnitude of the damage in tissues would depend upon local conditions.
A reaction scheme is proposed, based upon the observed products, showing initial
formation of a dihydrocytosine intermediate leading to each of the four products
examined (Figure 16). It is well established that ring-saturated dihydro-cytosine
intermediates are extremely susceptible to hydrolytic deamination (45, 46). A cytosine
residue in DNA (7) could react with HOC1 to yield the 5-chloro (2) or 6-chloro (J)
intermediates. The 5-chloro intermediate (2) could dehydrate to C1C (6) or deaminate to
the dihydrouracil intermediate (4) and then dehydrate to C1U (7). The 6-chloro
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intermediate (5) could eliminate HC1, generating HOC (8) or deaminate to the
corresponding dihydro uracil analog (5) and then dehydrate to HOU (9).
Control studies of the deamination of the deoxynucleotides, CldC and HOdC, by
hydrolysis and derivatization under the conditions above revealed the deamination to be
minor: 1.6% and undetectable for C1U and HOU respectively. The degree of
deamination of C1C to C1U in our oligonucleotide reaction was approximately 2.5%
(Table 3). The amount of C1C deamination is only slightly larger than expected during
oligonucleotide hydrolysis and derivatization (1.6%) indicating that most of the 5-chloro
intermediate (Figure 16, 2) dehydrates to C1C without deamination. The deamination of
HOC to HOU was substantially greater, with approximately 23% of the HOC
deaminating to HOU, (Table 3) indicating that the 5-hydroxy intermediate (Figure 16, 3)
is substantially more prone to deamination prior to dehydration than is the 5-chloro
intermediate.
Combining the corresponding cytosine and uracil products for the initial
chlorination versus oxidation, we can determine that the relative chlorination of cytosine
(C1C + C1U) occurs with a frequency of 54% and oxidation (HOC and HOU) at 46%
(Table 3). Overall, the chlorination and oxidation reactions appear very similar in
magnitude. The product yields provided by this experiment represent average results for
the three potential cytosine targets at positions 1, 5, and 6. Using the unlabeled
oligonucleotide did not allow us to determine if substantial deviations in reactivity occur
at any one of the potential reaction sites or if any of the C1C formed at the CpG site.
The reactivity of a given cytosine residue toward HOC1, as well as the relative
formation of the potential products shown in Figure 16, could depend upon local DNA
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Figure 16. Reaction Scheme for the conversion of a cytosine residue to the reaction
products, C1C (6), C1U (7) HOC (8), and HOU (9).
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sequence and structure. Neighboring bases could alter the steric accessibility of the
cytosine 5-6 bond to the reactive intermediates, and potentially alter the ultimate fate of
the intermediates formed. Because the biological impact of these cytosine reaction
products could be sequence specific, we examined potential differences in the reactivity
of cytosine at a CpG dinucleotide relative to other sequence positions. While GC/MS
and HPLC/MS methods are highly sensitive and provide a high level of certainty for
adduct identification (47-53), these methods require chemical or enzymatic hydrolysis
prior to analysis, resulting in the loss of all sequence-dependent information.
Alternatively, mass spectrometry methods can be used to sequence intact
oligonucleotides containing modified bases including C1C (42, 54-56). However, these
methods are designed for relatively homogenous preparations in which most of the
molecules present contain a specific modification located at a predominant, if not
exclusive position.
In order to directly investigate the sequence-specific questions posed here, we
applied a method referred to as mass-tagging. With this method, target and non-target
cytosine residues are differentially enriched with stable isotopes using solid-phase
oligonucleotide synthesis. Presuming the presence of the isotope does not substantially
alter reaction kinetics, which is unlikely with the molecules reported here, the mass
spectra of the resulting reaction products can be used to reveal the relative reactivity of
the target and non-target cytosine residues.
The reactions with HOC1 were repeated with the oligonucleotide containing
enriched cytosine at positions 1 and 5 (Figure 9). The total product yield with 500 pM
HOCL, 37°C and 1 hour, as indicated by the sum of the four products examined was of
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the same magnitude: 77.2 nmoles/jimol cytosine formed with the enriched
oligonucleotide versus 103.5 for the unenriched oligonucleotide (Table 3). If we examine
the overall yield of the four products, the trend remains C1C > HOC > HOU > C1U with
product percentages of 51%, 36%, 11% and 2 %, respectively. The similarity in the
product yields between the two experiments indicates the reproducibility of the reaction
and the chemical similarity of the unenriched and enriched oligonucleotides. Repeat
experiments yielded similar overall and relative amounts of reaction products formed.
Closer examination of the mass spectra of the products derived from the enriched
oligonucleotide allows comparison of the unenriched CpG at position 6 with the sum of
the enriched cytosine residues at position 1 and 5. Observation of a 316 line in the
spectrum of C1C derived from the enriched oligonucleotide unequivocally proves that
C1C can form within the CpG dinucleotide (Figure 15 A). The overall product yield for
the four products examined at the target CpG site and the sum of the enriched 1 and 5
positions are 27 nmoles/pmol cytosine and 51 nmoles/pmol cytosine respectively,
indicating that the overall reactivity at the CpG site is not substantially different than the
sum of the other two sites.
Upon examination of the remaining mass spectra in Figure 15, we can further
determine that all four products do form at the unenriched target CpG position. The
relative product yields are C1C > HOC > HOU > C1U, mirroring the trend observed with
the unenriched oligonucleotide. The percentages of the four products at the CpG site are
65%, 24%, 8% and 3%, differing slightly from the non-CpG positions. The product yield
at the enriched, non-CpG sites is C1C ~ HOC > HOU > C1U. The product percentages
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are 43%, 43%, 12% and 2 % respectively. We note that these yields represent the sum of
the reactions at the 1 and 5 positions.
The overall product yields at the unenriched CpG site (Figure 9, position 6, target
CpG site) and the sum of the two enriched sites (positions 1 and 5) are similar; however,
the product distribution is somewhat different. At the two non-CpG enriched positions,
oxidation (HOC + HOU) represents 55% of the total reactivity while chlorination (C1C +
C1U) is 45%. In contrast, chlorination at the CpG site (C1C + C1U) is 68%, while
oxidation (HOC +HOU) represents 32%. Validation of the proposed reaction scheme
represented in Figure 16 will require additional theoretical work. However, the
difference in relative product distribution reported here between the CpG site and the
other cytosine sites could potentially be explained by the orientation of attack of the
reactive species with formation of the dihydro intermediates 2 and 3. Local sequence
could influence the relative orientation of attack, but apparently does not substantially
alter the magnitude of reaction. We cannot determine from the experiments performed
here if there is a significant difference between the 1 and 5 positions; however, the above
results argue against large sequence-dependent differences in reactivity.
At the CpG site, deamination of C1C to C1U is only 4% whereas deamination of
HOC is 25%. At the other sites deamination of C1C to C1U is 4% and deamination of
HOC to HOU is 22%. Although the initial formation of the oxidation versus chlorination
products is apparently different at the two sites, the tendency to deaminate is similar. The
deamination of C1C seen in this experiment is slightly larger than in the experiment with
the unenriched oligonucleotide.
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We can conclude from these studies that HOC1 can cause both C1C and HOC at
both CpG and non-CpG sites, with a slight bias toward chlorination at the CpG sites. As
reported previously (17-19) the formation of C1C at CpG sites could mimic 5mC,
resulting in aberrant methylation and epigenetic changes. To date, no repair activity has
been identified for C1C, suggesting it might be a persistent form of DNA damage
accumulating at sites of inflammation, consistent with a proposed role in epigenetic
modification.
In contrast to C1C, the other damage products C1U, HOC and HOU could lead to
transition mutations at both CpG and non-CpG sites. Repair activities have been
identified for each of these bases (57-62), which might reduce their mutagenic potential.
However, HOC is considered to be one of the most mutagenic of all damage products.
Transition mutations at cytosine positions, and at the CpG dinucleotide in particular,
account for many of the single base changes observed in human tumors (63-65). While
spontaneous deamination of 5mC is often the explanation for transition mutations at CpG
dinucleotides, HOCl-mediated damage as described here might also contribute to these
observed mutations.
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A. Abstract
While the last thirty years chronicles an extensive effort to understand the damage
to DNA caused by reactive oxygen species (ROS), little research has examined the
chemical damage to the histone proteins found in chromatin. Hypochlorous acid (HOC1),
the primary product of activated neutrophils, is known to damage both DNA and
proteins. This report describes the use of mass spectrometry to quantitate the formation of
3-chlorotyrosine and 3,5-dichlorotyrosine, stable and unique markers of protein damage
caused by HOC1, in the core histone proteins. Our results indicate that up to 25% of the
tyrosine in histone proteins become chlorinated by excess HOC1. We also observe
significant formation of 3-chlorotyrosine and 3,5-dichlorotyrosine at low HOC1
concentrations and short reaction times. We use mass spectrometry to identify the
tyrosine residues on each histone protein that are chlorinated based on the observation of
chlorine-containing peptides following protease digestion of histone proteins exposed to
HOC1. The tyrosine residues preferentially chlorinated by HOC1 are generally within 3
residues of a lysine or histidine residue, further implicating the initial formation of
chloramines in the efficient chlorination of tyrosine residues. The methods and results
described here should further our understanding of how HOC1 produced at sites of
inflammation might damage chromatin.
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B. Abbreviations
HOC1: hypochlorous acid, NaOCl: sodium hypochlorite, ROS: reactive oxygen
species, H2O2: hydrogen peroxide, NADPH: oxidized form of nicotinamide adenine
dinucleotide phosphate, BSA: bovine serum albumin, TFA: trifluoroacetic acid, TFE:
trifluoroethanol, GC-NCI-MS: gas chromatography - negative chemical ionization
mass spectrometry, CID: collision induced dissociation, TOF: time of flight, MALDI:
matrix assisted laser desorption ionization, ESI: electrospray ionization
C. Introduction
Flypochlorous acid (HOC1) is the primary reactive oxygen species (ROS)
produced by activated neutrophils at sites of inflammation. The phagocytic leukocytes,
which include neutrophils, monocytes, and macrophages, all generate reactive oxygen
and chlorine species to kill invading microorganisms (7, 2). The production of HOC1 is
accomplished by the action of NADPH oxidase, superoxide dismutase, and
myeloperoxidase (2). These enzymes accelerate the production of HOC1 from oxygen.
Studies estimate that up to 80% of the hydrogen peroxide (H2O2) generated by activated
neutrophils is utilized to form concentrations of HOC1 in the micromolar to low
millimolar range (4-11).
Phagocytic leukocytes normally engulf bacteria and fuse myeloperoxidase
containing granules with the bacteria containing vesicle to form a phagosome (12, 13).
However, the reactive oxygen species produced by phagocytes can also damage host
tissues (3, 11). Leukocytes can secrete active myeloperoxidase into the extracellular
environment (7, 14). NADPH oxidase is normally assembled in the phagosome
membrane; however, trafficking of NADPH can be disrupted and instead fuse with the
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plasma membrane to create extracellular superoxide (15-17). The presence of
extracellular superoxide and myeloperoxidase is sufficient to generate extracellular HOC1
since superoxide (O2") spontaneously dismutates to form H2O2 (18). Evidence of
extracellular HOC1 generation is found in vivo, for example, when examining human
atherosclerotic plaques that contain HOCl-specific damage products (19, 20).
Hypochlorous acid oxidizes DNA bases to form 5-hydroxyluracil, 5hydroxycytosine, and thymine glycol (21). While these oxidized bases are also observed
when DNA is exposed to other reactive oxygen species, 8-chloroguanosine, 8chloroadenosine, 5-chlorocytosine, and 5-chlorouracil are chlorinated bases that are
unique products of HOC1 or reactive chloramines generated by HOC1. When human cells
in culture are exposed to 300 pM HOC1 for 10 minutes, Badouard et al. observed 5chlorocytosine, 8-chloroadenine, and 8-chloroguanine in extracted DNA (22). Using a
monoclonal antibody specific for HOC1 damaged DNA, Kawai et al. demonstrated the
presence of HOC1 damaged DNA at sites of inflammation in the lung and liver of mice
(23). Additionally, studies of intracellular glutathione levels in erythrocytes exposed to
extracellular HOC1 indicate that the cell membrane is readily crossed by HOC1 (24, 25).
These findings suggest that extracellular hypochlorous acid is capable of damaging the
chromatin of cells at sites of inflammation.
Approximately 147 base-pairs of DNA in human cells are wrapped twice around a
histone octamer composed of two copies each of the core histones H2A, H2B, H3, and
H4 to form a nucleosome. Nucleosomes, unbound DNA, and the linker histone HI are
then packaged into higher order chromatin structure. The core histones are also subject to
numerous post-translational modifications, including acetylation, methylation,
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phosphorylation, and ubiquitination, occurring primarily at specific amino acid residues
in the histone tails. These modifications form a so-called “histone code” that regulates
access to associated DNA by DNA binding and/or modifying proteins (26-28). While the
biological significance of most post-translational modifications has yet to be elucidated,
the critical role that known modifications play in DNA replication, transcription, and
DNA repair suggest that damage to histone proteins may adversely affect their biological
function.
In addition to DNA, HOC1 is also known to react with proteins generating
numerous damage products. The ability of HOC1 to oxidize and chlorinate protein
functional groups has been extensively studied using model compounds (29, 30). HOC1
oxidizes the sulfur containing amino acids methionine and cysteine. The free amines on
lysine and histidine residues are chlorinated by HOC1 to form chloramines that can
further react. The chloramines at the N-terminus and lysine residues can decompose to
form an aldehyde that can participate in cross-linking reactions with DNA or between
proteins (31). HOC1 is also known to form 3-chlorotyrosine, a stable product unique to
the action of HOC1 on proteins. Finally, HOC1 slowly reacts with the protein backbone
and can lead to fragmentation.
Hypochlorous acid is expected to rapidly react with histone amines, thiols,
thioethers, and disulfides. The second order rate constants for the oxidation or
chlorination of methionine, cysteine, histidine, and lysine side chains have been reported
with values between 104 and 107 IVT's"1 (30). By contrast, the reaction of HOC1 with
double stranded DNA is slow (101 M'V1); although the exposed amines of single
stranded DNA react faster (102 - 104 M'V1) (32, 33). The oxidation of methionine or
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cysteine residues in proteins is likely reversible due to the actions of the protein repair
enzymes, methionine reductase {34, 55) and glutathione reductase {36-38). The reaction
between HOC1 and lysine or histidine residues results in the formation of an unstable
chloramine that can react further with DNA (57) or other amino acids such as tyrosine
{39, 40). The kinetics of protein damage indicate that histone proteins might be targets of
extracellular HOC1.
In this report, we expose the core histone proteins to HOC1 to determine their
susceptibility to damage. We use mass spectrometry to measure the formation of 3chlorotyrosine and 3,5-dichlorotyrosine, two potential markers that are stable and unique
damage products of HOC1. The direct chlorination of tyrosine to form 3-chlorotyrosine is
slow (40 NT's'1) (57); however, a tyrosine residue within the YXXK sequence motif can
be rapidly chlorinated {30, 39). The core histone proteins are rich in the basic amino acids
histidine, arginine, and lysine. Furthermore, histones H2A, H2B, and H4 all have the
YXXK/KXXY sequence motif identified as a preferred site of tyrosine chlorination. The
results from these experiments provide the basis for efforts to detect HOC1 damage of
histone proteins in human cells at sites of inflammation.
D. Materials and Methods
Sodium hypochlorite (NaOCl) was purchased from Sigma-Aldrich and purified
by extraction with ethyl acetate to remove chloride and other decomposition products as
previously published {41). This “chloride free NaOCl” was stored at 4 °C and diluted into
purified water daily before use. Isotope-labeled tyrosine ( C9) was purchased from
Cambridge Isotope laboratories (Andover, MA). The 13C9 tyrosine (2 mM) was reacted
with 2 mM HOC1 for 60 minutes at 37 °C to form 13C9-3-chlorotyrosine which was
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HPLC purified to remove impurities including unreacted tyrosine and the aldehyde
product 4-hydroxyphenylacetaldehyde {42). The procedure of Allevi et al. was used to
IT*

.IT*

synthesize C9-3,5-dichlorotyrosine from Cg-tyrosine {43). These stable-isotope labeled
internal standards were characterized by GC-NCI-MS, HPLC, and UV spectroscopy and
indicated a purity of > 98%. The mass spectra for all three isotope labeled internal
standards are shown in Figure 17. The heptafluorobutyric acid anhydride used for
derivatization of tyrosine prior to GC-NCI-MS and all other chemicals were obtained
from Sigma-Aldrich (St. Louis, MO).
The calf thymus histone proteins H2A, H2B, H3, and H4 were purchased from
Roche Applied Science (Indianapolis, IN) and used without further purification. The
sequences of the major bovine histone proteins are shown below with tyrosine residues
shown in bold font. The major variant protein for histones H2A and H3 have identical
sequences in humans and bovine; the H2B and H4 sequences differ by a single residue
between the major variants. The post-translational modifications on the core histone
proteins from calf thymus have been characterized {44).

Histone H2A
SGRGKQGGKARAKAKTRSSRAGLQFPVGRVHRLLRKGNYAERVGAGAPV
YLAAVLEYLTAEILELAGNAARDNKKTRIIPRHLQLAIRNDEELNKLLG
KVTIAQGGVLPNIQAVLLPKKTESHHKAKGK

Histone H2B
PEPAKSAPAPKKGSKKAVTKAQKKDSKKRKRSRKESYSVYVYKVLKQVH

pdtgisskamgimnsfvndiferiageasrlahynkrstitsreiqtav
RLLLPGELAKHAVSEGTKAVTKYTSSK

110

Figure 17. GC-NCI-MS allows separation and quantitation of tyrosine and its chlorinated
products. A) Tyrosine and its chlorinated products, 3-chlorotyrosine and 3,5dichlorotyrosine, were analyzed as their n-propyl heptafluorobutyric derivatives by
GCMS using negative ion chemical ionization. B) The gas chromatogram for 3chlorotyrosine and 3,5-dichlorotyrosine (gray curve) is magnified 20-fold and offset
above the unmagnified curve. C) The resulting spectra for tyrosine, 3-chlorotyrosine, and
3,5-dichlorotyrosine include approximately equal amounts of unenriched compound and
the corresponding 13C9-standards.
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Histone H3
ARTKQTARKSTGGKAPRKQLATKAARKSAPATGGVKKPHRYRPGTVALR
eirryqkstellirklpfqrlvreiaqdfktdlrfqssavmalqeacea

YLVGLFEDTNLCAIHAKRVTIMPKDIQLARRIRGERA
Histone H4
SGRGKGGKGLGKGGAKRHRKVLRDNIQGITKPAIRRLARRGGVKRISGL
IYEETRGVLKVFLENVIRDAVTYTEHAKRKTVTAMDVVYALKRQGRTLY
GFGG

Peptide synthesis and Purification
The peptide Ac-RLLRKGNYAERYGAG, corresponding to residues 32 - 39 of
histone H2A, was synthesized on an ABI model 433A peptide synthesizer using fast
FMOC chemistry. The FMOC amino acids (with side chain protection) were purchased
from Advanced Chemtech (Louisville, KY) and the resin (F[-Gly-2-Cl(Trt)) was
purchased from Novabiochem (San Diego, CA). Prior to deprotection of the N-terminal
FMOC protecting group, the N-terminus of any unreacted amino groups were acetylated
using a solution of 0.34 M acetic anhydride and 0.34 M triethylamine in N-methyl-2pyrrolidinone (NMP). Following the final deprotection, the N-terminus of the peptide
was acetylated using acetic anhydride (95 pL) in NMP (3 ml) with triethylamine (140
pL). The protecting groups and resin support were cleaved from the peptide using reagent
B (trifluoroacetic acid (TFA) / phenol / water / triisopropylsilane, 88:5:4:2). After
filtering off the resin and concentrating the remaining solution, the peptide was
precipitated in cold diethyl ether. The ether was removed and the dried peptide dissolved
in water with the minimum amount of acetonitrile necessary for solubility. We used
reverse phase F1PLC to obtain purified peptides. Our typical HPLC conditions used a Cl 8
column (Varian Dynamax, 250 x 21.4 mm, 300A, 5 pm) with a gradient of 20 - 80%
mobile phase B (acetonitrile and 0.085% TFA); mobile phase A contained aqueous 0.1%
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TFA. The sequence of purified peptides was confirmed by MS/MS using a
ThermoFinnigan LCQ Deca XP mass spectrometer and analytical HPLC showed a purity
of >95%.
All reactions contained 10 mM phosphate buffer at pH 7.5 and were equilibrated
at 37 °C prior to addition of hypochlorous acid (HOC1). The pKa of HOC1 is 7.5 resulting
in equal concentrations of hypochlorous acid and its conjugate base, hypochlorite.
However, we use the term “hypochlorous acid” to refer to both the acid and its conjugate
base in the text of this paper. The reaction was initiated by the addition of HOC1 and
stopped by the addition of a 10 fold excess of methionine after the desired reaction time.
Fresh dilutions of NaOCl were made each day into 0.1 M NaOH and the concentration of
the stock was determined using the absorbance at 290 nm (8290 nm = 350 Nf'cm"1) (45,
46). Dilutions of the NaOCl stock were then made into water and, if necessary, the pH
was adjusted with phosphoric acid prior to addition to tyrosine containing solutions.
The quantity and concentrations of extracellular HOC1 produced in vivo are not
known. However, estimates of the HOC1 generating capability of 1 x 106 neutrophils (the
number of neutrophils found in 0.25 ml of blood) over a 1 to 2 hour time period range
from 60 to 560 nanomoles of HOC1 (3, 7-10, 47). Therefore, most researchers assume
physiological HOC1 concentrations are in the micromolar to low millimolar range and
large excesses of HOC1 can be generated over the 1 - 2 day half-life of activated
neutrophils at sites of inflammation. As histone proteins are likely exposed to lower
HOC1 concentrations in the cell nucleus, we used HOC1 concentrations of 10 and 100
pM.
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The peptide Ac-RLLRKGNYAERY GAG (5 pM) was exposed to 100 pM HOC1
for 60 minutes at 37°C. Of the tyrosine observed when the peptide was not exposed to
HOC1, only 8% (compared to 74% for histone H2A) of the tyrosine was recovered as
tyrosine, 3-chlorotyrosine, or 3,5-dichlorotyrosine using our GC-NCI-MS method. Our
data (see results and discussion sections) describing the recovery of starting tyrosine
indicate that the formation of tyrosine damage products other than tyrosine, 3chlorotyrosine, or 3,5-dichlorotyrosine occur following exposure to HOC1. For
comparison to the estimates of tyrosine chlorination observed in peptides derived from
histone proteins after protease cleavage, we normalized the measured tyrosine, 3chlorotyrosine, and 3,5-dichlorotyrosine when this H2A peptide is exposed to HOC1 to
100 percent and included these results in Table 4.
GC-NCI-MS
We modified the previously published method of the Heinecke laboratory to
quantitate the presence of tyrosine, 3-chlorotyrosine, and 3,5-dichlorotyrosine following
reaction with HOC1 {48, 49). Following the addition of methionine to consume unreacted
HOC1, we added stable-isotope labeled (13C9) tyrosine (1 nanomole), 3-chlorotyrosine
(0.1 nanomole), and 3,5-dichlorotyrosine (0.1 nanomole). Following vacuum
centrifugation of the sample to remove water, we hydrolyzed the protein with 6N HBr
and 1% phenol for 24 hours at 120 °C. As complete hydrolysis is necessary for accurate
quantitation of tyrosine, 3-chlorotyrosine, and 3,5-dichlorotyrosine, we verified that 24
hours was a sufficient reaction time. The expected quantity of tyrosine in our samples
was known given the UV absorbance at 274 nm (8274 nm

1368 M^cm'1). After adding

13C9-tyrosine as an internal standard, we varied the hydrolysis reaction time and then used

115

GC-NCI-MS to measure the amount of tyrosine. At reaction times less than 3 to 6 hours,
the measured tyrosine was lower than expected and increased with increasing reaction
time. With reaction times between 6 and 24 hours the UV absorbance and GC-NCI-MS
measures of tyrosine content agreed within 20 percent. We chose to use a 24 hour
hydrolysis reaction to maintain consistency with published literature. The variation in
tyrosine content between samples of histone proteins derived from the same dilution of
the histone stock have less than 5% variation with a hydrolysis time of 24 hours.
Following hydrolysis, the HBr was removed using vacuum centrifugation. The
two part derivatization began by heating tyrosine and its chlorinated derivatives at 65°C
for one hour in 3.5M HBr in n-propanol. The HBr/n-propanol solution was removed
using vacuum centrifugation. The final derivatization step to form the heptafluorobutyric
analogs was accomplished by heating for 10 - 20 minutes at 65°C in 60 pL of an ethyl
acetate/heptafluorobutyric acid anhydride solution (3:1). These samples were suitable for
analysis by GC-NCI-MS and stable for at least 3 days.
Samples were analyzed on an Agilent Technology’s 6890N GC/5973N MSD
instrument operating in the chemical ionization mode. We used a DB-5ms column with
dimensions of 30 m x 0.25 mm x 0.25 pm; the column was preceded by 10 m of an
unreactive guard column (duraguard). The inlet temperature was 250 °C. The GC column
was initially held at 150 °C for 2 minutes followed by a 20 °C/minute gradient to 250 °C
and a 30 °C/minute gradient to 280 °C. The column temperature was then held at 280 °C
for 10 minutes. The GCMS interface was heated to 280 °C while the MS source and MS
quadrupole were heated to 150 °C. Methane was used as the reagent gas for negative
chemical ionization (NCI) with a flow rate of 40%.
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The standard curves for the heptafiuorobutyric n-propyl derivatives of tyrosine, 3chlorotyrosine, and 3,5-dichlorotyrosine were linear (R2 > 0.99). The standard curves
used 0.1 - 15 nanomoles tyrosine and 0.01 - 1 nanomoles of 3-chlorotyrosine and 3,5dichlorotyrosine. The stock concentration of tyrosine, 3-chlorotyrosine, and 3,5dichlorotyrosine were determined by UV spectroscopy using the molar absorptivity
values of S274nm = 1368 NT'cm'1, S278nm = 1879 M^cm'1 , and S286.5nm = 1424 NT’cm'1,
respectively (50).
MALDI-TOF
Following the addition of methionine to react with excess HOC1, porcine
pancreatic trypsin or staphylococcus aureus GluC were added, and the histones were
digested at 30 °C for 2-24 hours. The digestion was then concentrated by vacuum
centrifugation. The resulting peptide mixture was purified by HPLC on a Phenomenex
Jupiter Cl8 column (150 x 2 mm, 5 pm, 300A) to remove salt, methionine, and oxidized
methionine. We used a binary gradient with a mobile phase of A) 0.1% TFA in purified
water and B) 0.85% TFA in HPLC grade acetonitrile. We used 5% B for 5 minutes at a
flow rate of 0.2 ml/min followed by a linear gradient to 40% B over 40 minutes. The
peptides were usually collected in 1 ml fractions and then lyophilized. Peptides were then
dissolved in aqueous 30% acetonitrile with 0.1% TFA. Peptide-containing fractions were
generally examined individually but were sometimes combined in order to estimate the
extent of chlorination when the chlorinated peptide and unreacted peptide eluted in
different HPLC fractions. All MALDI samples used a-cyano-4-hydroxycinnamic acid
(HCCA) as the matrix, which was prepared as a saturated solution in aqueous 30%
acetonitrile with 0.1% TFA. MALDI samples were prepared using the dried-droplet
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method. MALDI-TOF spectra were acquired on a Bmker Auto flex using the installed
FlexControl 2.4 software. The mass-to-charge ratio was calibrated using a commercial
peptide solution containing angiotensin I and II, substance P, bombesin, renin substrate,
clipped ACTH residues 1-17 and 18-39, and somatostatin spotted near our samples.
For fractions containing the unmodified peptide and chlorinated peptides, the relative
percentages were estimated by using the Bmker FlexAnalysis 2.4 software to integrate
the area for each peptide mass envelope in the same spectrum.
LCMS
We also examined the peptides derived from protease digestion of histone
proteins using liquid chromatography - mass spectrometry (LCMS) to verify the peptide
sequence using collision induced fragmentation (CID) data. Following HPLC purification
and desalting as described above, the peptide-containing fractions were combined,
concentrated, and dissolved in aqueous 5% acetonitrile with 0.1% TFA. Samples were
analyzed on a Waters Micromass Q-TOF ultima equipped with a Waters CapLC XE
pump and an Agilent Zorbac SB-C18 column (5 pm particles, 150 x 0.5 mm). The
HPLC flow rate was 6 pL/minute with gradient from 2-85% acetonitrile in aqueous
0.1% TFA. We estimated the relative amounts of chlorinated and unmodified peptides by
integrating the chromatographic area of an appropriate mass present in the survey scans.
We used the masses corresponding to the same charge state and tried to select masses
with little interference. In all cases, we observed that the order of retention on Cl 8
columns was unmodified peptide followed by monochlorotyrosine-containing and then
dichlorotyrosine-containing peptides.
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Circular Dichroism Spectroscopy
Circular dichroism (CD) samples were prepared by diluting 100 pM histone
stocks 10-fold into either 25 mM phosphate, pH 7.5, or an aqueous trifluoroethanol (TFE)
solution to give a final solution that is 25% TFE (v/v) and 25 mM phosphate, pH 7.5. The
concentrations of the stock solutions were determined by UV spectroscopy using the
tyrosine absorbance of S274nm = 1368 M^cm"1. CD spectra were recorded using a JASCO
model J720 spectropolarimeter with a nitrogen flow rate of 5 L/min. The wavelength and
degree ellipticity scales were calibrated using a reference d-10-camphorsulfonic acid
(CSA) sample assuming that the CSA minimum corresponds to [0] 192.5

-15,600.

Typical spectral accumulation parameters were a time constant of 0.25 s and a scan rate
of 100 nm/min with a 0.2 nm step resolution over the range 185-270 nm with 16 scans
averaged for each spectrum. The accumulated average spectra were trimmed at a dynode
voltage of 600 prior to baseline subtraction and smoothing using the reverse Fourier
transform procedure in the JASCO software. CD spectral values for peptides are
expressed in units of residue molar ellipticity (deg-cm /residue-dmol). The final
concentration of the histone proteins in a 0.1 cm path length cell was 10 pM. The
temperature of the CD cell was equilibrated at 37°C for 15 minutes prior to acquisition of
the spectra.
CD spectra were converted into secondary structure estimates using the CDSSTR
(57, 52) algorithm as implemented on the Dichroweb site (53, 54). All possible reference
sets, given the wavelength range of the experimental spectrum, were used to estimate the
percentage of secondary structure. The result with the best fit was determined using the
normalized root mean squared deviation (NRMSD) (55). The a-helix and p-strand
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conformations are divided into two classes for the CDSSTR reference spectra. Short
segments of a-helix and p-strand conformations that are 4 and 2 residues, respectively, or
shorter in length are classified as distorted; longer a-helix and P-strand conformations
usually have regular geometries. The remaining conformations are classified as turns and
unordered.
Statistical Analysis
The statistical significance (p) of observed differences was calculated using the
student t-test in Excel. All analysis compared two pairs of three measurements and used a
two-tailed analysis. The significance of GC-NCI-MS measures of tyrosine, 3chlorotyrosine, and 3,5-dichlorotyrosine formation were compared when histones were
and were not exposed to HOC1 and with and without TFE.
E. Results
GC-NCI-MS can simultaneously quantitate tyrosine and chlorinated tyrosine
residues.
One goal of this report was to develop a sensitive and quantitative method to
measure the formation of 3-chlorotyrosine and 3,5-dichlorotyrosine when histone
proteins are exposed to hypochlorous acid (HOC1). Gas chromatography-negative
chemical ionization-mass spectrometry (GC-NCI-MS) of heptafluorobutyric n-propyl
derivatives satisfies both requirements (49, 56-58). Furthermore, we extended the use of
heptafluorobutyric n-propyl derivatives to the measurement of 3,5-dichlorotyrosine,
another potential chlorination product when HOC1 reacts with proteins.
Prior to derivatization, 13C9-tyrosine, 13C9-3-chlorotyrosine, and 13C9-3,5dichlorotyrosine were added to our sample as stable-isotope labeled internal standards.
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Using 1 nanomole of labeled tyrosine and 100 picomoles each of 3-chlorotyrosine and
3,5-dichlorotyrosine, we determined that our standard curves were linear (R2 > 0.99) over
the range of analyte concentrations examined in this report. Our limit of detection for
tyrosine (417 m/z) and chlorotyrosine (451 m/z) were approximately 70 attomoles
(injected onto the GC column) while the sensitivity towards dichlorotyrosine (m/z 683)
was approximately 190 attomoles when operating the mass spectrometer in the selected
ion monitoring (SIM) mode. These detection limits are consistent with those reported for
3-chlorotyrosine {49).
The derivatives of tyrosine, 3-chlorotyrosine and 3,5-dichlorotyrosine were
readily separated by GC (Figure 17). The observed mass spectrum of the tyrosine
derivative indicates the ready loss of HF (595 m/z) and the heptafluorobutyl group (417
m/z). The NCI-MS spectrum of the 3-chlorotyrosine derivative is similar. We used the
base peak with masses of 417, 451, and 683 m/z, respectively, for the quantitation of the
heptafluoro n-propyl derivatives of tyrosine, 3-chlorotyrosine, and 3,5-dichlorotyrosine.
The base peak of derivatized tyrosine and 3-chlorotyrosine corresponds to the loss of a
heptafluorobutyl group while the base peak for the 3,5-dichlorotyrosine derivative
corresponds to the molecular ion. In Figure 17, the mass spectra also show the
contribution of the relevant internal standard with a shift of 9 mass units; the samples
contained approximately equal concentrations of the unenriched and stable-isotope
enriched compounds.
We also verified that our method resulted in the expected amount of tyrosine in
control samples not exposed to HOC1. We used UV spectroscopy to determine the
concentration of N-acetyltyrosine of the core histones contained in each sample; we used
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a molar absorptivity of £278 nm = 1368 MT’cm"1 to determine the tyrosine concentration of
our samples (50). The molar absorptivity of the core histones was determined using the
number of tyrosine residues present in each protein. After the histone proteins were
exposed to HOC1, methionine was added to consume excess oxidant, the stable isotope
internal standards were added, and the histone proteins were hydrolyzed in 6N HBr with
1% phenol for 24 hours as previously reported (49). We generally did not add methionine
to control samples not exposed to HOC1 although added methionine had no observable
effect on our GC-NCI-MS measurements. The determination of tyrosine in control
samples was usually 80 to 120 percent of our expected value using the tyrosine content
determined by UV spectroscopy; the sample to sample variation using the same histone
stock was usually less than 5 percent. We also varied our HBr hydrolysis reaction time to
determine if shorter times resulted in incomplete hydrolysis and decreased our recovery
of tyrosine relative to the internal standard 13C9-tyrosine. We determined that hydrolysis
was complete after 6 hours at 120 °C and resulted in the expected tyrosine content in
control samples. To avoid the formation of 3-chlorotyrosine during acid hydrolysis, we
used HBr instead of HC1 for hydrolysis and minimized the presence of chloride ions in
our reactions (48). Control reactions with 8 to 200 nanomoles of N-acetyltyrosine
resulted in a maximum of 0.1 percent conversion to 3-chlorotyrosine due to the artifactual
chlorination during hydrolysis. We did not observe artifactual formation of 3,5dichlorotyrosine under these conditions. All of the reported experiments were
accompanied with a control experiment to determine the background formation of 3chlorotyrosine and 3,5-dichlorotyrosine during hydrolysis.
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Hypochlorous acid efficiently chlorinates tyrosine residues in histone proteins.
We examined the chlorination of N-acetyltyrosine as a reference for the direct
chlorination of tyrosine by HOC1 under our reaction conditions. To account for cysteine,
methionine, lysine, and histidine residues on histone proteins that react rapidly with
HOC1 (30), we increased the quantity of added HOC1 so that the bulk HOC1
concentration a few seconds after initiation of the reaction was constant for solutions
containing one of the histone proteins or N-acetyltyrosine. We assumed that each lysine,
histidine, methionine, or cysteine residue in the histone proteins could react rapidly with
one equivalent of HOC1. The HOC1 concentrations in reactions with histone proteins
ranged between 36.0 and 43.4 pM for an effective 10 pM concentration and between 126
and 133.4 pM for an effective 100 pM concentration. For example, 1 pM of histone H2B
has 26 pM of reactive molecules (20 lysines, 3 histidines, 2 methionines, and 1 Nterminal amine) that would consume 26 pM of 36 pM of HOC1 leaving an “effective”
concentration of 10 pM HOC1 to react with remaining tyrosine (5 pM). As seen in Figure
18, only small quantities of 3-chlorotyrosine are formed when N-acetyltyrosine is
exposed to 10 or 100 pM HOC1. The formation of 3,5-dichlorotyrosine when Nacetyltyrosine was exposed to HOC1 was not different than control. However, 7-12 and
14-25 percent of the tyrosine residues in the core histone proteins are chlorinated at an
effective HOC1 concentration of 10 and 100 pM, respectively.
The resulting tyrosine chlorination in the core histone proteins compared with Nacetyltyrosine suggests the presence of specific mechanisms that enhance the formation
of 3-chlorotyrosine and 3,5-dichlorotyrosine when histone proteins are exposed to HOC1.
Our results indicate that significant (paired, two-tail student t-test, p < 0.05) chlorination
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Figure 18. The tyrosine residues in core histone proteins are chlorinated to 3chlorotyrosine (A) and 3,5-dichlorotyorisne (B) when exposed to hypochlorous acid. All
reactions were performed at pH 7.5 and 37°C; the error bars represent the standard
deviation of three samples. The concentration of each reactant was chosen so that the
total tyrosine concentration was 5 pM with a total tyrosine content of 8 nanomoles per
reaction. The concentration of hypochlorous acid was chosen to result in an effective
concentration of 10 or 100 pM (see text and Material and Methods). The quantity of
tyrosine and chlorinated tyrosine residues was measured using GC-NCI-MS.
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of tyrosine residues occurs within minutes even at HOC1 concentrations as low as 10 |aM.
Increasing the reaction time to 60 minutes provides no more than a 2 - 4 fold increase in
chlorinated tyrosine residues. Our reactions with an effective concentration of 10 jaM
contained a 6.4 - 8.7 fold excess of HOC1 relative to total tyrosine (held constant at 5
jaM) in the core histones. Reactions with an effective concentration of 100 jaM contained
a 25.3 - 26.7 fold excess of HOC1 relative to total tyrosine (5 jaM). Despite excess HOC1,
we saw less than 25% of the tyrosine converted to 3-chlorotyrosine or 3,5dichlorotyrosine suggesting that some tyrosine residues are not as efficiently chlorinated.
The simultaneous measurement of tyrosine, 3-chlorotyrosine, and 3,5dichlorotyrosine allowed us to determine if additional tyrosine damage products might be
formed. When the core histone proteins were exposed to HOC1 for 60 minutes at 126
133.4 jaM, the total of tyrosine, 3-chlorotyrosine, and 3,5-dichlorotyrosine was only 74,
82, 52, and 49% for histones H2A, H2B, H3, and H4, respectively, when compared to
the amount of tyrosine observed in a parallel reaction without exposure to HOC1. The
loss of tyrosine was less when the core histone proteins were exposed to 32 - 43.7 jaM
HOC1; the recovered tyrosine was 87, 100, 85, and 82%, respectively, for histones H2A,
H2B, H3, and H4.
We also determined the formation of 3-chlorotyrosine and 3,5-dichlorotyrosine
when HOC1 was not present in excess (Figure 19). In these reactions, we used 10 or 100
jaM HOC1 for all reactions and the concentration of each histone protein was chosen so
that the resulting concentration of tyrosine was 50 jaM. The ratio of HOC1 to tyrosine is
thus 0.2 and 2.0 at 10 and 100 jaM HOC1, respectively. For the results shown in Figure
19, we did not observe a loss in tyrosine that was not accounted for by the corresponding
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Figure 19. Limited H0C1 also chlorinates tyrosine residues to 3-chlorotyrosine (A) and
3,5-dichlorotyrosine (B) of histone proteins. All reactions were performed at pH 7.5 and
37°C; the error bars represent the standard deviation of three samples. Values marked by
an X are marginally significant (p between 0.25 and 0.05). The concentration of each
reactant was chosen so that the total tyrosine concentration was 50 pM with a total
tyrosine content of 8 nanomoles per reaction. The quantity of tyrosine and chlorinated
tyrosine residues was measured using GC-NCI-MS. The ratio of HOC1 to tyrosine
residues is 0.2 and 2.0 at 10 and 100 pM, respectively.
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formation of 3-chlorotyrosine and 3,5-dichlorotyrosine. While the measured formation of
3-chlorotyrosine and 3,5-dichlorotyrosine increased at all HOC1 concentrations and
exposure times, the statistical significance of the observed tyrosine chlorination was
marginal (p of 0.05 - 0.25) at lower HOC1 concentrations and after only a one minute
exposure. These results demonstrate that tyrosine chlorination can occur even in the
presence of an excess of lysine, histidine, cysteine, and methionine residues that rapidly
react with HOC1.
Tyrosine residues near lysine or histidine residues are efficiently chlorinated.
To better understand the formation of 3-chlorotyrosine and 3,5-dichlorotyrosine in
the core histone proteins, we used mass spectrometry to characterize the presence of
tyrosine, 3-chlorotyrosine, and 3,5-dichlorotyrosine in peptides derived from the core
histone proteins using the proteases trypsin and GluC. Following exposure of core
histone proteins to an effective HOC1 concentration of 100 pM for one hour at 37 °C and
using methionine to consume unreacted oxidant, we digested the histone proteins with the
proteases trypsin or GluC and then used mass spectrometry to identify the peptides
containing chlorinated tyrosine residues. The high resolution of time-of-flight (TOF)
mass spectra are particularly advantageous for identifying chlorine containing peptides as
the presence of chlorine-35 and chlorine-37 isotopes in a 3 to 1 ratio yields a
characteristic mass envelope. Figure 20A shows the mass spectrum obtained on a
MALDI-TOF mass spectrometer of a histone H3 peptide where Tyr-41 is unmodified,
monochlorinated (+34 m/z for monoisotopic peak) and dichlorinated (+68 m/z for
monoisotopic peak).
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Figure 20. MALDI-TOF and LC-ESI-Qtof data demonstrating the chlorination of
tyrosine residues on histones H3. Histone H3 was digested at 37°C overnight with GluC
in 10 mM phosphate buffer, pH 7.5, following a 60 minute exposure to 133 pM
hypochlorous acid. (A) One resulting peptide from histone H3, RYRPGTVALRE, and its
mono and dichloro derivatives shown with MALDI-TOF spectra are predicted to have
m/z values of 1317.739, 1351.700, and 1385.661, respectively. (B) The peptides
AYLVGLFE derived from histone H3 with tyrosine, 3-chlorotyrosine, or 3,5dichlorotyrosine is shown as a LC-ESI-Qtof chromatographic plot of the monoisotopic
masses for the single charged ions at 911.5, 945.5, and 979.5 m/z, respectively.
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We can qualitatively estimate the ratio of tyrosine, 3-chlorotyrosine, and 3,5dichlorotyrosine present at each tyrosine residue of the core histone proteins using mass
spectrometry. First, the relative intensities of a tyrosine containing peptide and its 3chlorotyrosine and 3,5-dichlorotyrosine containing analogs are obtained from the
MALDI-TOF spectra. Our assumption is that substituting one or two hydrogen atoms for
a chlorine atom in the context of a peptide will have negligible impact on the efficiency
of ionization. The relative intensities are thus assumed equal to relative concentrations
and normalized to 100%. When the tyrosine-containing peptide and its chlorinated
analogs elute in different HPLC fractions during desalting, we combine the necessary
fractions prior to analysis by MALDI-TOF. Second, we can estimate the relative
quantities on our LC-ESI-Q-TOF system. We extract the chromatographic areas of the
tyrosine-containing peptide and its 3-chlorotyrosine and 3,5-dichlorotyrosine analogs
and, assuming equal ionization efficiencies, convert the relative areas into relative
concentrations and normalize to 100%. We further assume that the minor changes in
mobile phase (up to 3% more acetonitrile between the tyrosine containing and the 3,5dichlorotyrosine containing peptides) during the HPLC separation have a minor impact
on the ionization efficiency during electrospray ionization. Examples of the data
produced by this method are shown in Figure 20.
We summarize our resulting estimates of chlorination at each histone tyrosine
residue in Table 4. Where multiple peptide sequences containing a specific tyrosine
residue are produced during protease cleavage due to a missed cleavage site or non
specific cleavage, we used the peptide with the best signal to noise to generate the
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Table 4. Specific tyrosine residues in core histone proteins are efficiently chlorinated.
Histone peptides were generated by endoprotease digestion with trypsin or GluC
following a 60 minute exposure to 130 ± 4 pM hypochlorous acid in 10 mM phosphate,
pH 7.5, at 37 °C. The percentage of tyrosine, 3-chlorotyrosine and 3,5-dichlorotyrosine
containing peptides was estimated using mass spectrometry as described in the methods
section unless the expected modification was not detected (ND). Underlined tyrosine
residues are efficiently chlorinated by hypochlorous acid.

Histone H2A
Tyr-39
Tyr-50
Tyr-57
Histone H2B
Tyr-37,40,42
Tyr-83
Tyr-121
Histone H3
Tyr-41
Tyr-54
Tyr-99
Histone H4
Tyr-51
Tyr-72
Tyr-88
Tyr-98

Tyr (%)

CfTyr (%)

Cl2Tyr(%)

69
82

7
2

88

24
16
12

ND

LRKGNYAERVG
AGAPVYLAAVL
AAVLE YLTAEI

62
43
28

20
32
32

18
25
40

RKESYSVYVYKVLKQ
SRLAHYNKRST
KAVTKYT s sk

67
83
76

18
11
20

15
6
4

kkphryrpgtv
REIRRYQKSTE
EACEAYLVGLF

97
98
50
87

3
2
18
6

ND
ND
32
7

ISGLIYEETRG
RDAVTYTEHAK
AMDVVYALKRQ
QGRTLYGFGG
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Local Histone Sequence

estimates given in Table 4. Wherever possible, we used peptides that contain a single
tyrosine residue to obtain unambiguous estimates.
All tyrosine residues were observed by mass spectrometry in peptides following
digestion with the endopeptidases GluC and trypsin. With the exception of Tyr-39 of
histone H2A, we also observed these unmodified peptides following exposure to HOC1.
We thus chose to examine chlorination of Tyr-39 of histone H2A by using the synthetic
peptide RLLRKGNYAERVGAG with an amino-terminal acetyl group. The estimate of
Tyr-39 chlorination in Table 4 is based on a GC-NCI-MS measurement of tyrosine, 3chlorotyrosine, and 3,5-dichlorotyrosine using the above synthetic peptide as described in
the Materials and Methods.
Our survey of the specific tyrosine residues of the core histone proteins that are
chlorinated by HOC1 indicates that Tyr-39 of histone H2A, Tyr-83 and Tyr-121 of
histone H2B, Tyr-41 of histone H3, and Tyr-88 of histone H4 are readily damaged to
form 3-chlorotyrosine and/or 3,5-dichlorotyrosine. On histone H3, Tyr-37, Tyr-40, and
Tyr-42 were always found on the same peptide that was also significantly chlorinated.
Analysis of the MS/MS fragmentation data indicated that Tyr-42 was chlorinated to form
3-chlorotyrosine and 3,5-dichlorotyrosine suggesting that Tyr-42 was the major site of
chlorination while not ruling out chlorination of Tyr-37 and Tyr-40. All of the tyrosine
residues that are most readily chlorinated by HOC1 are found within four residues of a
lysine and/or a histidine residue.
Trifluoroethanol does not affect the chlorination of tyrosine in core histone proteins.
Using the molecular modeling software Insightll, we modeled reasonable sidechain conformations for tyrosine and lysine or histidine with a regular a-helix backbone
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or an extended conformation to determine if the chlorine atom of lysine or histidine
chloramines can approach the tyrosine carbons at the 3 or 5 positions. In an extended
conformation, only YXH or YXK should enhance tyrosine chlorination. In an a-helix
conformation, the sequence motifs YK, YH, YXXK, YXXH, YXXXK, and YXXXH
should also allow the chloramine to react with the tyrosine ring. Under the low salt
conditions used in this report, the histone proteins are not folded into the native structure
seen in an octamer or nucleosome (59).
We used circular dichroism (CD) to characterize the secondary structure of the
calf thymus histone proteins used in this report (Figure 21). The CD spectra in low salt
buffer and aqueous trifluoroethanol (TFE) were converted into secondary structure
estimates (Table 5) using the CDSSTR (51, 52) algorithm on the Dichroweb site (53, 54).
In 25 mM phosphate buffer at pH 7.5 with and without 25% TFE (v/v), the CD spectra of
samples containing a single core histone proteins indicated that the individual histone
proteins are unstructured with the presence of 46 - 60 percent unordered peptide and/or
turns. This is in contrast to the a-helical secondary structure observed by CD
spectroscopy for histone complexes such as the H2A-H2B dimer, (H3-H4)2 tetramer, and
the histone octamer (60, 61).
We attempted to alter the secondary structure of the histones using the addition of
high salt or cosolvent. TFE is a cosolvent known (62) to promote a-helical as well as
other local secondary structure such as [3-hairpins (63, 64) and the Trp-cage (65, 66). We
selected TFE instead of high NaCl concentrations since chloride ions can chlorinate
tyrosine during hydrolysis. We also observed the formation of visible aggregates when
histones H2A, H2B, H3, or H4 were individually diluted into 2M NaCl. Only histone H4
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Figure 21. Trifluoroethanol (TFE) induces minor changes in the secondary structure of
the core histone proteins from calf thymus. The concentration of each histone protein was
10 pM. All spectra were acquired at a pH of 7.5 and 37°C. The shift to longer
wavelengths of the minimum near 222 nm upon addition of TFE for histones H2A, H2B,
and H3 suggests the stabilization of p- and/or y-tums (67). Addition of TFE to histone H4
stabilizes helical conformations.
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Table 5. Secondary structure estimates of calf thymus histone proteins in buffer and
aqueous TFE. CD spectra were converted into secondary structure estimates using the
CDSSTR algorithm as implemented on the Dichroweb site. NRMSD, normalized root
mean squared deviation, is a standard measure of fit between the theoretical and
experimental spectra. The often distorted and short segments of a-helix and |3-strand with
4 and 2 residues or fewer, respectively, are reported separately from the longer, more
regular secondary structure.
Histone Solvent a-helix a-helix P-strand p-strand Turns Unordered NRMSD
regular distorted regular distorted
H2A
H2B
H3
H4

Buffer

8

9

17

9

19

38

0.017

TFE

11

9

16

9

17

38

0.021

Buffer

17

14

11

8

20

29

0.007

TFE

16

13

13

9

21

30

0.012

Buffer

7

9

18

11

24

32

0.018

TFE

9

7

16

9

19

40

0.022

Buffer

5

8

18

11

26

32

0.013

TFE

19

13

12

9

20

26

0.006

138

becomes more helical (13 % in buffer, 32% in TFE) following addition of TFE to 25%.
The CD spectra of histones H2A, H2B, and H3 in aqueous 25% TFE, notably the shift of
the negative peak at circa 222 nm to longer wavelengths, indicates the increased presence
of y and/or p turns (67-69). The contribution of these turns was not fully accounted for in
the secondary structure estimates obtained using the CDSSTR since most of the observed
NRMSD resulted for difficulty fitting the CD spectra between 220 and 235 nm.
We also used our GC-NCI-MS method to determine the formation of 3chlorotyrosine and 3,5-dichlorotyrosine when the samples contain 25% TFE. The effect
of TFE on the chlorination of tyrosine was conducted in parallel to the results shown in
Figure 19. When compared to the formation of 3-chlorotyrosine and 3,5-dichlorotyrosine
in 25 mM phosphate buffer, pFf 7.5, the addition of TFE had negligible effects on the
chlorination of tyrosine in the core histone proteins (Figure 22). The lack of a significant
difference in chlorotyrosine formation when histone H4 is in buffer or aqueous 25% TFE
suggests that the presence of TFE doesn’t significantly affect the chlorination chemistry
of tyrosine residues in the core histone proteins. We also conclude that the structural
changes induced by 25% aqueous TFE were not sufficient to alter the observed
chlorination by HOC1 in the histone proteins.
F. Discussion
In this paper we report the first examination of the sites and extent of tyrosine
chlorination when the histone proteins H2A, H2B, H3, and H4 are exposed to
hypochlorous acid. In addition to measuring the formation of 3-chlorotyrosine, we also
used our GC-NCI-MS method to quantitate the formation of 3,5-dichlorotyrosine.
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Figure 22. Trifluoroethanol does not alter the formation of 3-chlorotyrosine and 3,5dichlorotyrosine. All reactions were performed at pH 7.5 and 37°C; the error bars
represent the standard deviation of three samples. The concentration of each reactant was
chosen so that the total tyrosine concentration was 50 pM with a total tyrosine content of
8 nanomoles per reaction. The concentration of hypochlorous acid was chosen to result in
a [HOC1] of 10 or 100 pM. Samples with and without TFE were processed in parallel
during exposure to HOC1, HBr hydrolysis, and derivatization for GC-NCI-MS. The
quantity of tyrosine and chlorinated tyrosine residues was measured using GC-NCI-MS.
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While a couple of published reports used HPLC and GCMS methods to measure
both 3-chlorotyrosine and 3,5-dichlorotyrosine {70, 71), this work is the first using
histone proteins. Chapman et al. determined that 2.3 and 0.3 percent of tyrosine was
chlorinated to form 3-chlorotyrosine and 3,5-dichlorotyrosine, respectively, when a 72
pM bovine serum albumin (BSA) solution was reacted with 3 mM HOC1 for 30 minutes
{70). Hawkins and Davies (77) observed that approximately 10 and 2.5 percent of
tyrosine was chlorinated to form 3-chlorotyrosine and 3,5-dichlorotyrosine, respectively,
when a 230 pM soybean trypsin inhibitor (STI) solution was reacted with 2.3 mM HOC1
for 15 minutes. By contrast, exposure of hen egg lysozyme (340 pM) to 3.4 mM HOC1
for 15 minutes resulted in only 0.8 percent chlorination of the tyrosine residues (77). Our
data (Figure 19) for the histone proteins under the conditions most similar to the above
reports indicated that approximately 5 to 15 percent of tyrosine residues are chlorinated
to form 3-chlorotyrosine and 3,5-dichlorotyrosine.
Hawkins and Davies also noted a loss of total tyrosine when soybean trypsin
inhibitor is exposed to HOC1; they attributed this loss to protein fragmentation and poor
recovery during precipitation. Our sample processing is not susceptible to tyrosine losses
as we add our internal standards directly to the histone containing samples following
addition of methionine to consume the remaining HOC1. During hydrolysis, any losses in
tyrosine, 3-chlorotyrosine, or 3,5-dichlorotyrosine are accounted for by equivalent losses
in our internal standards. A 24 hour reaction in HBr at 120°C gave complete hydrolysis
yielding the expected quantity of tyrosine. These results indicate that 3-chlorotyrosine
and 3,5-dichlorotyrosine are not the only tyrosine damage products formed by HOC1,
particularly at higher excesses.
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Additional oxidation products of tyrosine include 3,4-dihydroxyphenylalanine
(DOPA) and di-tyrosine (72). We did not observe evidence of tyrosine oxidation to form
DOPA in the bovine histones and our GC-NCI-MS method is not capable of detecting di
tyrosine. Hawkins and Davies (77) state that they did not observe DOPA formation when
soybean trypsin inhibitor was exposed to HOC1; they did measure di-tyrosine although at
levels too low to explain the loss of tyrosine. However, chlorination of phenol with
excess HOC1 is known to eventually produce chloroform (73). We suspect that 3,5dichlorotyrosine can react further with HOC1 to form as yet uncharacterized products.
Like the core histone proteins, BSA and soybean trypsin inhibitor have tyrosine residues
near a lysine or a histidine residue; 16 of 21 tyrosine residues for BSA and 3 of 4 tyrosine
residues in soybean trypsin inhibitor are within three residues of a histidine or lysine
residue. By contrast, only minor quantities of 3-chlorotyrosine were observed in E. coli
GroEL and hen egg lysozyme where only 1 of 7 tyrosine residues and 4 of 9 tyrosine
residues, respectively, are within four residues of a histidine or lysine residue(77, 74).
The current understanding of the mechanism of tyrosine chlorination in proteins is
based upon the observations of chlorotyrosine formation in short peptides and
apolipoprotein A-l {39, 75). Bergt et al. used mass spectrometry to determine that Tyr192 of apolipoprotein A-l is efficiently chlorinated and argued that Lys-195 in the
sequence YHAK facilitated chlorination of Tyr-192 (39). The Heinecke laboratory, based
on the chlorination of tyrosine in synthetic peptides, concluded that the sequence motif
1 o

YXXK or KXXY favors tyrosine chlorination, particularly in cc-helicies. Pattison and
Davies, however, note that histidine can form a chloramine that in turn can accelerate
tyrosine chlorination and they point out the presence of His-193 in the sequence of high
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density lipoprotein {40). Thus, chlorination of tyrosine residues by HOC1 is accelerated
when HOC1 reacts with a nearby amine to form a chloramine that can then chlorinate the
tyrosine residue.
We qualitatively measured the chlorination of each tyrosine residue in histones
H2A, H2B, H3, and H4 to estimate the influence of nearby residues on the susceptibility
of chlorination by HOC1 (Table 4). The first report of a sequence motif that promotes
efficient chlorination of tyrosine residues identified the YXXK motif in Apolipoprotein
A-l as a hot-spot for tyrosine chlorination. In the core histone proteins, Tyr-39 of H2A,
Tyr-37 and Tyr-40 of H2B, and Tyr-88 of H4 are found in this sequence motif.
Approximately 50% of Tyr-88 becomes chlorinated forming 3-chlorotyrosine and 3,5dichlorotyrosine while less than 15% of the other three tyrosine residues in histone H4
were detected within chlorinated peptides. By contrast, Tyr-50 and Tyr-57 of histone
H2A and Tyr-99 of histone H3, which are not near a histidine or lysine residue, become
approximately 10-25 percent monochlorinated. The few percent of monochlorination
formation as seen in Tyr-51 and Tyr-72 of histone H4 is likely due to the direct
chlorination of tyrosine by HOC1. We also estimate that approximately 30+% of Tyr-41
in histone H3, which is located in the -KPHRY- sequence, becomes chlorinated
suggesting a role for His-39 and/or Lys-37 in the chlorination of Tyr-41. Our survey of
tyrosine residues chlorinated by HOC1 in the core histone proteins suggests that the
YXXK/KXXY sequence motif is not the only sequence motif that becomes efficiently
chlorinated. Like the Heinecke laboratory, we also observed that some tyrosine residues
within the YXXK motif are not as efficiently chlorinated, possibly because the local
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secondary structure is not a-helical and therefore the lysine chloramine is not spatially
located near the tyrosine residue {39).
Modeling studies suggest that the local secondary structure might also alter the
probability that a lysine or histidine chloramine will efficiently chlorinate a tyrosine
residue nearby in sequence. One approach to determining the importance of protein
structure is to compare the chlorination of tyrosine residues in a protein to chlorination of
N-acetyltyrosine in a mix of N-acetyl amino acids that corresponds to the amino acid
composition of the protein. The use of amino acid mixes does not separate the role that
local secondary structure and tertiary structure have in the efficient chlorination of
tyrosine residues. In this report, we determined the formation of 3-chlorotyrosine and 3,5dichlorotyrosine when trifluoroethanol (TFE) was added to induce secondary structure
changes in the histone proteins. We selected TFE instead of high NaCl concentrations as
TFE does not lead to visible histone aggregation and did not affect subsequent hydrolysis
and GC-NCI-MS measurements. Circular dichroism spectroscopy of the histone proteins
in buffer with and without added TFE indicated that 25% TFE did not result in an
increase in a-helical structure except for histone H4. Furthermore, addition of 25% TFE
did not result in significant differences in the formation of 3-chlorotyrosine or 3,5dichlorotyrosine (Figure 22). These results indicate that TFE will be a useful cosolvent to
determine the role of secondary structure on the efficient tyrosine chlorination by nearby
histidine and lysine residues in a peptide or protein system other than individual histone
proteins.
Our interest in the core histone proteins in large part derives from their biological
importance in regulating access to DNA during replication, transcription, and DNA
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repair. The results in this report should help us determine if histone proteins are damaged
in human tissues at sites of inflammation. Extracellular HOC1 can encounter histone
proteins contained in neutrophil extracellular traps (NETs), secreted chromatin and
granule proteins that appear to kill bacteria and may be medically relevant to sepsis (76,
77). The literature also suggests that HOC1 can cross the cell membrane and damage the
DNA packaged by histones in human cells (24). Histone monomers synthesized in the
cytosol are assembled into dimers, tetramers and octamers that then package DNA into
nucleosomes (78, 79). This paper characterizes the damage to histone monomers; we are
in the process of examining the chlorination of histone complexes and nucleosomes that
are commonly found in cells.
The difference in physiochemical properties of 3-chlorotyrosine and 3,5dichlorotyrosine relative to tyrosine should also perturb histone structure and/or the
association of histone proteins. 3-chlorotyrosine and 3,5-dichlorotyrosine, which are
more strongly retained on Cl8 columns during HPLC with acidic buffers, are more
hydrophobic residues than tyrosine. The pKa values for phenol, 2-chlorophenol and 2,6dichlorophenol are 9.99, 8.56, and 6.79, respectively (80). The pKa for 4-methyl-2,6dichlorophenol is 7.19 suggesting that the phenol group of dichlorotyrosine is easily
ionized at physiological pH (80). Furthermore, we predict that oxidation of methionine
and cysteine residues or formation of reactive aldehydes at the lysine side chain can also
impair histone function in human cells.
In addition to mutations in their DNA, human cancers also contain abnormal
DNA methylation patterns in CpG islands and post-translational modifications in the
histone tails that are perturbed from the modifications found in normal cells (81-85). A
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genetic model of cancer attributes initiation of carcinogenesis to gene mutations (86).
However, an epigenetic model of cancer is gaining recognition whereby damage to the
epigenetic state of a cell, DNA methylation and histone modifications, can contribute to
the progression of a damaged cell towards a cancerous state (87). Like DNA damage
caused by reactive species and other chemical carcinogens, damage of histone proteins by
these reactive molecules may contribute to human disease and explain, in part, the
observed association between inflammation and the subsequent development of cancer
(88, 89).
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CHAPTER FIVE

Discussion
DNA damage and tissue inflammation have both been associated with cancer
development in man (Lu et al, 2006; Hussain and Harris, 2007). The results of emerging
biochemical studies, including those reported here may provide a mechanistic link
between the two. It is well known that activated neutrophils generate reactive HOC1, a
highly effective antimicrobial agent that can simultaneously cause substantial collateral
damage to normal tissues (Priitz, 1998; Priitz, 1996; Hawkins et al, 2002; Kulcharyk and
Heinecke, 2001; Schraufstarter et al, 1990; Whiteman et al, 1997; Masuda et al, 2001;
Chen et al 2002; Kawai et al, 2004; Kato et al 2005). HOC1 is known to react with thiols,
nucleotides, proteins and other biological substrates (Priitz, 1996).
Several previous studies have demonstrated that HOC1 reacted with DNA can
cause a complex array of damaged bases, and in particular, pyrimidine damage products
(Priitz, 1996; Whiteman et al 1997; Henderson et al, 1999; Masuda et al, 2001; Whiteman
et al, 2002; Chen et al, 2002; Henderson et al, 2003; Jiang et al, 2003; Kawai et al 2004;
Badouard et al, 2005; Takeshita et al, 2006). Thymine yields primarily cis and trans
glycols whereas cytosine generates both chlorination and oxidation damage products
(Whiteman et al, 1999). The sum of the thymine products has been found to be similar in
magnitude to the cytosine-generated products. In contrast to hydrogen peroxide, HOC1
generates only small amounts of oxidized purines, including 8-oxoguanine (Whiteman et
al, 1999).
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Among the HOCl-generated cytosine damage products, HOC, HOU and C1U have
been reported in several previous studies (Priitz, 1996; Whiteman et al 1997; Henderson
et al, 1999; Masuda et al, 2001; Whiteman et al, 2002; Chen et al, 2002; Henderson et al,
2003; Jiang et al, 2003; Kawai et al 2004; Badouard et al, 2005; Takeshita et al, 2006).
The chlorination damage product C1C has been reported in substantially fewer studies
(Henderson et al, 1999, Masuda et al, 2001, Badouard et al 2005), perhaps due to its
apparent lability under DNA hydrolysis conditions, primarily its deamination to C1U.
In Chapter 2, we describe the methods for the chemical synthesis of
oligonucleotides containing C1C. Our primary interest in developing a synthetic method
for the preparation of CIC-containing oligonucleotides was to provide substrates for
subsequent biophysical and biochemical studies aimed at understanding the biological
consequences of chlorinated pyrimidines in DNA. The method reported here is simple
and efficient and accomplishes this initial goal. Our primary concern with the
preparation of the CIC-containing oligonucleotides was the potential formation of C1U by
either hydrolysis during synthesis or deamination following synthesis. After
characterizing C1C containing oligonucleotides with a barrage of mass spectrometric
techniques and verifying that the major product contained C1C and not C1U, we wanted a
more sensitive assay to measure low amounts of C1U in our oligonucleotides. We
exploited the specificity of E. coli mismatch uracil DNA glycosylase (MUG) to remove
C1U paired with G that would result from the deamination of C1C to show that the
oligonucleotide containing C1C is better than 98% pure (Figure 6).
Using these oligonucleotides, we have optimized methods for the recovery of C1C
from DNA. A significant challenge in the analysis of damaged bases in DNA is that
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artifactual changes, in this case, C1C to C1U, can occur in the process of converting the
oligonucleotide to its constituent monomers for subsequent analysis. The lability of C1C
in duplex was difficult to assess prior to having an oligonucleotide substrate with a
known amount of C1C prior to work up for analysis. We then examined some conditions
used to chemically hydrolyze oligonucleotides prior to derivatization and GC/MS
analysis (Chen et al 2002). We observed that acid hydrolysis for 90 min with 60%
formic acid at 150°C did not completely deaminate the C1C from the oligonucleotides
(Figure 7A). Indeed, approximately 25% of the original C1C still remained unchanged
even under these conditions, and 5% remained after 3 h. These results indicate that the
measured amounts of cytosine chlorination damage products may have underestimated
the extent of damage. We extended these studies, and we have observed that the silylation
reported in Chapter 3 with MTBSTFA containing 1% TBDMCS results in substantially
less deamination; perhaps the steric bulk surrounding the derivatized 4-amino group
inhibits subsequent deamination. In control experiments using the latter, the conversion
of C1C to C1U from acid hydrolysis and derivatization never exceeded 2%.
Using synthetic oligonucleotides with C1C at specific sequence contexts from the
method developed in chapter 2, our group showed that C1C in a CpG sequence context
mimics 5-methylcytosine (5mC) by enhancing the binding of methyl-CpG-binding
domain (MBD) of methyl-CpG-binding protein 2 (MeCP2) (Valinluck et al, 2005).
Additional studies show that C1C can cause inappropriate cytosine methylation by human
DNA maintenance methyltransferase, DNMT1 (Valinluck and Sowers, 2007). Therefore,
although C1C would not be expected to be miscoding, the formation of C1C in the CpG
dinucleotide could perturb epigenetic patterns in DNA by causing inappropriate
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methyltransferase-mediated cytosine methylation and by increasing the binding affinity
of methyl-binding proteins involved in subsequent histone modification and chromosome
condensation (Valinluck et al, 2005; Valinluck and Sowers, 2007).
In chapter 3, a reaction scheme is proposed, based upon the observed products,
showing initial formation of a dihydrocytosine intermediate leading to each of the four
products examined (Figure 16). It is well established that ring-saturated dihydrocytosine
intermediates are extremely susceptible to hydrolytic deamination (Boorstein et al, 1990;
O’Donnell et al, 1994). A cytosine residue in DNA (7) could react with HOC1 to yield
the 5-chloro (2) or 6-chloro (2) intermediates. The 5-chloro intermediate (2) could
dehydrate to C1C (6) or deaminate to the dihydrouracil intermediate (£) and then
dehydrate to C1U (7). The 6-chloro intermediate (2) could eliminate HC1, generating
HOC (8) or deaminate to the corresponding dihydrouracil analog (5) and then dehydrate
to HOU (9).
In a previous study, the amount of HOC generated in DNA by HOC1 exceeded the
amounts of HOU by a factor of approximately two (Whiteman et al, 1999). In the results
in chapter 3, we observe that the HOCl-generated levels of HOC are approximately three
times higher than the amounts of HOU, consistent with overall lower levels of product
deamination with the methods reported here. In the previous study, C1U and HOU levels
were similar (Whiteman et al, 1999), however, here we observe substantially lower levels
of C1U relative to HOU, again reflecting lower levels of C1C deamination using the
methods reported here. With the inclusion of C1C reported here, the array of damaged
bases generated by HOC1 constitutes a unique chemical damage spectrum.
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The biological consequences of DNA damage have historically focused upon
mutagenesis. Among the HOCl-generated DNA damage products, C1U, HOC and HOU
would be mutagenic, and collectively, they generate approximately half of the cytosinederived HOCl-mediated damage products (Table 3). All of these damage products can be
excised by glycosylases of the base-excision repair pathway (Wagner et al, 1996;
Fujimoto et al, 1997; Brandon et al, 2000; Liu et al, 2002; Bennett et al, 2006). In
contrast, C1C would not be expected to be mutagenic, and no repair activities have yet
been reported for C1C (Kang et al, 2004; Valinluck et al, 2005). In contrast to
mutagenesis, the similar size of the 5-chlorine substituent of C1C and the 5-methyl group
of 5mC led us to suspect that C1C might mimic 5mC in critical DNA protein interactions
(Valinluck et al, 2005; Valinluck and Sowers, 2007).
In higher eukaryotes, cytosine methylation patterns, in concert with specific
modified histone proteins, comprise an epigenetic code essential for tissue and cellspecific control of gene expression (Lanzuolo and Orlando, 2007; Smith et al, 2007).
Disruption of the epigenetic code can result in inappropriate gene expression, and such
defects are commonly observed in human tumors. Although aberrant cytosine
methylation, leading to the silencing of tumor suppressor genes, is a characteristic of
many human tumors (Palii and Robertson, 2007; Gal-Yam et al 2008), mechanisms
leading to inappropriate methylation have not yet been identified. The identification of
C1C as an endogenous inflammation-mediated damage product led to in vitro studies that
confirmed that C1C can mimic 5mC in enhancing the binding of methylation-sensitive
DNA binding proteins and in directing the inappropriate methylation of previously
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unmethylated sites by the human cytosine methyltransferase, Dnmtl (Valinluck et al,
2005; Valinluck and Sowers, 2007).
In eukaryotes, cytosine methylation occurs predominantly in the CpG
dinucleotide. If adventitious chlorination of DNA, generating C1C, can result in
perturbations of the epigenetic code, it must occur at the CpG dinucleotide. Current
analytical methods for examining DNA damage (LaFrancois et al, 1998; England et al,
1998; Dizdaroglu, 1998; Theruvathu et al, 2005; Malayappan, et al, 2007), although
highly sensitive and specific, could not be used to establish C1C formation at the CpG
dinucleotide because acid or enzymatic hydrolysis required prior to analysis results in the
loss of sequence-specific information. Examination of a complex mixture of intact
oligonucleotides by mass spectrometry methods (Huber and Oberacher, 2001; Fountain et
al 2003; Antsypovich et al, 2007) also would not reveal the sequence-specific
information desired. We therefore adapted a mass-tagging approach as reported here.
The resulting mass differences between C1C formed at a target CpG site versus C1C
formed at non-CpG sites (Figure 15) provides direct evidence for the capacity of HOC1 to
form C1C at the CpG dinucleotide in duplex DNA.
The overall reactivity of cytosine residues at CpG and the two non-CpG sites,
measured as the sum of the four products examined, is roughly equivalent (Table 3). In
both cases, the yield of the cytosine product, C1C and HOC is approximately seven times
the sum of the corresponding deamination products C1U and HOU. In contrast,
differences in the yield of chlorination versus oxidation products are observed. At the
non-CpG sites, the sum of the chlorination products (C1C and C1U) is similar to the sum
of the oxidation products (HOC and HOU). However, the sum of the chlorination
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products at the CpG site is approximately twice that of the oxidation products. The
mechanistic basis for this difference is as yet unknown, however, it might be ascribed to
sequence-specific structural differences that modify the orientation of the initial attacking
species leading to a greater relative amount of the 5-chloro intermediate (2 in Figure 16),
as opposed to the 5-hydroxyl intermediate (3 in Figure 16) at the CpG site.
The results reported here identify C1C as a significant HOCl-mediated DNA
damage product and confirm that the collection of cytosine-derived damage products
comprise a diagnostic signature of HOCl-mediated DNA damage. The use of the mass
tagging method allows direct demonstration of the formation of C1C at a CpG
dinucleotide.
Evidence of cellular DNA damage by HOC1 and the close proximity of more
readily reactive histone protein side chains led us to hypothesize that the core histone
proteins can also be damaged by HOC1. Two potential markers that are relatively stable
and unique damage products of HOC1 are 3-chlorotyrosine and 3,5-dichlorotyrosine
(Chapman et al, 2000; Chapman et al, 2002). Tyrosine residues within the YXXK
sequence motif can be rapidly chlorinated (Pattison and Davies, 2001; Bergt et al 2004).
Histones H2A, H2B, and H4 all have the YXXK/KXXY sequence motif identified as a
preferred site of tyrosine chlorination (Bergt et al, 2004). While 3-chlorotyrosine and
3,5-dichlorotyrosine formation might directly affect histone function, 3-chlorotyrosine
and 3,5-dichlorotyrosine can be measured as markers of all types of HOC1 induced
damage of histone proteins. In chapter 4, we report the first examination of the sites and
extent of tyrosine chlorination when the histone proteins H2A, H2B, H3, and H4 are
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exposed to hypochlorous acid by measuring the formation of 3-chlorotyrosine and 3,5dichlorotyrosine using GC-NCI-MS.
Only small quantities of 3-chlorotyrosine are formed when N-acetyltyrosine is
exposed to 10 or 100 pM HOC1 (Figure 18). However, 7-12 and 14-25 percent of the
tyrosine residues in the core histone proteins are chlorinated at an effective HOC1
concentration of 10 and 100 pM, respectively. The resulting tyrosine chlorination in the
core histone proteins compared with N-acetyltyrosine suggests the presence of specific
mechanisms that enhance the formation of 3-chlorotyrosine and 3,5-dichlorotyrosine
when histone proteins are exposed to HOC1.
The HOCl-specific protein damage products 3-chlorotyrosine and 3,5dichlorotyrosine have been used as markers of inflammation mediated protein damage
(Zheng et al, 2004; Wu and Pizzo, 2001; Mita et al, 2004; Green et al, 2004; Chapman,
2002). Recently, Whiteman and Spencer found that 3-chlorotyrosine can be degraded
when exposed to peroxynitrite and activated inflammatory cells suggesting that
measurement of 3-chlorotyrosine alone could lead to an underestimation of the true
extent of protein chlorination (Whiteman and Spencer, 2008). The simultaneous
measurement of tyrosine, 3-chlorotyrosine, and 3,5-dichlorotyrosine allowed us to
determine if additional tyrosine damage products might be formed. When the core
histone proteins were exposed to effective pM 100 HOC1 for 60 minutes, the total of
tyrosine, 3-chlorotyrosine, and 3,5-dichlorotyrosine was only 74, 82, 52, and 49% for
histones H2A, H2B, H3, and H4, respectively, when compared to the amount of tyrosine
observed in a parallel reaction without exposure to HOC1. When a synthetic peptide, AcRLLRKGNYAERYGAG (5 pM), was exposed to 100 pM HOC1 for 60 minutes at 37°C,
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only 8% of the tyrosine was recovered as tyrosine, 3-chlorotyrosine, or 3,5dichlorotyrosine compared to the tyrosine observed when the peptide was not exposed to
HOC1. These results indicate that 3-chlorotyrosine and 3,5-dichlorotyrosine are not the
only tyrosine damage products formed by HOC1, particularly at higher excesses and are
consistent the findings of Whitman and Spencer. Additionally, the observation that
tyrosine degradation to as yet unidentified products was almost 10 times greater in a short
peptide with a specific sequence suggests that there may be sequence specificity in the
production of these unidentified degradation products.
We qualitatively measured the chlorination of each tyrosine residue in histones
H2A, H2B, H3, and H4 to estimate the influence of nearby residues on the susceptibility
of chlorination by HOC1 (Table 4). In the core histone proteins, Tyr-39 of H2A, Tyr-37
and Tyr-40 of H2B, and Tyr-88 of H4 are found in this sequence motif. Approximately
50% of Tyr-88 becomes chlorinated forming 3-chlorotyrosine and 3,5-dichlorotyrosine
while less than 15% of the other three tyrosine residues in histone H4 were detected
within chlorinated peptides. We also estimate that approximately 30+% of Tyr-41 in
histone H3, which is located in the -KPHRY- sequence, becomes chlorinated suggesting
a role for His-39 and/or Lys-37 in the chlorination of Tyr-41. Our survey of tyrosine
residues chlorinated by HOC1 in the core histone proteins suggests that the
YXXK/KXXY sequence motif is not the only sequence motif that becomes efficiently
chlorinated. Like the Heinecke laboratory, we also observed that some tyrosine residues
within the YXXK motif are not as efficiently chlorinated, possibly because the local
secondary structure is not ot-helical and therefore the lysine chloramine is not spatially
located near the tyrosine residue (Bergt et al, 2004).
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Pattison and Davies found that tertiary structure of small proteins, insulin and
lysozyme, facilitates secondary chlorine transfer reactions of chloramines formed on His
and Lys side chains by comparing chlorinated products in intact proteins to a mix of Nacetyl amino acids that corresponded to the amino acid composition of the respective
protein (Pattison and Davies, 2007). However, the use of amino acid mixes does not
separate the role that local secondary structure and tertiary structure have in the efficient
chlorination of tyrosine residues. In this study, we determined the formation of 3chlorotyrosine and 3,5-dichlorotyrosine when trifluoroethanol (TFE) was added to induce
secondary structure changes in the histone proteins. In buffer with and without 25% TFE
(v/v), the circular dichroism (CD) spectra of samples containing a single core histone
protein indicated that the individual histone proteins are unstructured with the presence of
46 - 60 percent unordered peptide and/or turns. Circular dichroism spectroscopy of the
histone proteins in buffer with and without added TFE showed that 25% TFE did not
result in an increase in ct-helical structure except for histone H4. Furthermore, addition of
25% TFE did not result in significant differences in the formation of 3-chlorotyrosine or
3,5-dichlorotyrosine (Figure 22). The lack of a significant difference in chlorotyrosine
formation when histone H4 is in buffer or aqueous 25% TFE suggests that the presence
of TFE doesn’t significantly affect the chlorination chemistry of tyrosine residues in the
core histone proteins. These results indicate that TFE will be a useful cosolvent to
determine the role of secondary structure on the efficient tyrosine chlorination by nearby
histidine and lysine residues in a peptide system or protein system other than individual
histone proteins.
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Conclusions and Future Directions
This series of studies culminates in the characterization of HOC1 mediated
damage products of DNA and histone proteins. A method to place C1C in synthetic
oligonucleotides (Chapter 2) provides a tool to study the biochemical and biophysical
properties of the HOC1 mediated DNA damage product, C1C. This tool was used to show
the formation of C1C in the CpG dinucleotide could perturb epigenetic patterns in DNA
by causing inappropriate methyltransferase-mediated cytosine methylation and by
increasing the binding affinity of methyl-binding proteins involved in subsequent histone
modification and chromosome condensation (Valinluck et al, 2005; Valinluck and
Sowers, 2007). Future studies using this tool include examining the structure, dynamics,
and coding potential of C1C using high field isotope-edited NMR and polymerase
extension assays.
In chapter 3, we show that when C1C deamination is minimized, C1C is the major
product of HOC1 mediated damage of cytosine in duplex DNA. Additionally, the use of
mass tagging provides direct evidence for the formation of C1C in the CpG sequence
context providing evidence that C1C could indeed perturb 5-methylcytosine dependant
epigenetic regulation. We observed a two fold increase in the yield of chlorination versus
oxidation products at the CpG site compared to the average of the two non-CpG sites
indicating some sequence specificity for the chlorination reaction. Future studies using
mass tagging could determine which sequences provide specificity.
In chapter 4, we report the first examination of the sites and extent of tyrosine
chlorination when the histone proteins H2A, H2B, H3, and H4 are exposed to
hypochlorous acid. As expected, we find that histone proteins are damaged by HOC1, and
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that the level of damage can be measured by using the marker, 3-chlorotyrosine and 3,5dichlorotyrosine. We observe that tyrosine chlorination is accelerated when the tyrosine
is located within 4 residues of a lysine or histidine. Furthermore, we find that 3chlorotyrosine and 3,5-dichlorotyrosine can further degrade to as yet unidentified
products. Further studies using model peptides and acetylated amino acids may shed
light on these products. Histone monomers synthesized in the cytosol are assembled into
dimers, tetramers, and octamers that then package DNA into nucleosomes (huger, 2006;
Park and huger, 2006). This study characterizes the damage to histone monomers. Future
studies could examine the chlorination of histone complexes and nucleosomes that are
commonly found in cells.
The results of this series of studies provide a better understanding of HOC1
damage products of DNA and histone proteins at sites of inflammation and shed light on
the mechanisms by which inflammation contributes to carcinogenesis. These results
strengthen the hypothesis that inflammation-mediated chromatin damage can result in
mutation as well as perturbations of the epigenetic code, and might provide a mechanistic
basis for the association between inflammation and cancer long suggested by
epidemiologic studies (Lu et al, 2006; Hussain and Harris, 2007).
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